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PSEUDO PELGER-HUËT ANOMALIES AS POTENTIAL BIOMARKERS FOR ACUTE 




The potential for malicious use of radiation, or radiation accidents could potentially lead 
to acute, high radiation doses to members of the public. Following an acute accidental exposure 
to high doses of radiation, medical intervention is pivotal to the survivability of the patient and 
the sooner the appropriate measures are taken the better the odds for survival. Early estimates of 
acute accidental radiation doses can be determined via biomarkers such as dicentric chromosome 
analysis or scenario reconstruction using computer software.  However, both take valuable time, 
and can be expensive.  Here, potentially faster, and cheaper quantitative biomarkers for radiation 
exposure were evaluated in acutely exposed Rhesus Macaques from the Wake Forest School of 
Medicine, Department of Comparative Medicine. Increased frequencies of abnormal neutrophils 
in peripheral blood, referred to as pseudo Pelger-Huët anomalies (PPHAs), have been shown to 
be potential biomarkers of radiation exposure in several scenarios, including the 1958 Y-12 
criticality accident and the radium dial painters. We have confirmed the PPHA morphology to be 
present in Rhesus Macaques and a dose response curve, a biokinetics model, and determination 
of background prevalence of the morphology has been constructed utilizing peripheral blood 
smears. The dose response curve consists of macaques that received doses ranging from 0 Gy to 
8.5 Gy (LD90/30) and a blood smear at a common time point post-irradiation. The biokinetics 
model utilized only 4 Gy exposures and blood smears taken periodically over 3.1 years post-
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irradiation. Results show a linear correlation between PPHA concentration and acute radiation 
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Scope and Purpose of this Project  
This study is intended to expand upon the methodologies available to biodosimetrists for 
early and retrospective dose estimations for individuals that have been exposed to ionizing 
radiation.  Radiation exposure can occur in several different ways to include but not limited to 
internal, external, chronic, acute, industrial accidents, environmental contamination, naturally 
occurring radioactive materials, criticality accidents, or combinations of the above.  Considering 
the multiple scenarios for accidental radiation exposures that have happened and could happen, 
tools for early dose assessment are vital to proper triage of patients and ultimately medical 
treatment.   
The pseudo Pelger-Huët anomalies (PPHA) assay is performed by taking a peripheral blood 
smear that has been stained with a nuclear staining dye such as Giemsa-Wright stain and 
evaluated using a light microscope to determine the percentage of neutrophils presenting the 
PPHA morphology. Previous research projects have shown promising results for chronic 
exposure from environmental sources, and preliminary data have been produced for acute 
exposure scenarios, but many questions have been left unanswered (Meehan, 2001 & Goans, 
2015).  Biological samples from acutely exposed rhesus macaques have been obtained to expand 
on the previously discovered evidence for the efficacy of the PPHA assay as a biomarker of 
radiation. This study hypothesizes that the PPHA assay will produce a statistically significant 
dose response model, and will have some degree of persistence following an irradiation incident.  
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Four specific aims were addressed in this study: (1) Establishing a baseline prevalence of 
PPHAs in the peripheral blood of rhesus macaques, (2) establishing a dose response curve across 
a variety of acute doses, (3) establishing a biokinetics and persistence model, (4) determining 
future study needs to utilize the PPHA assay for biodosimetry. 
Part one of this study consists of establishing a baseline prevalence of PPHAs in peripheral 
blood of rhesus macaques.  Goans et. al found that humans have a background prevalence of 
PPHAs of between 4.4 ± 0.4%, so it was assumed that rhesus macaques have a background 
prevalence as well. Background radiation is an important consideration for both the baseline and 
the persistence of PPHAs, as PPHA morphology may be induced by chronic low dose exposure.  
The baseline prevalence of PPHAs in rhesus macaques was hypothesized to be above zero, but 
below the baseline of humans due the majority of the primates being irradiated at 5.2 ± 1.3 years 
of age, while humans were much older thus accumulating much higher lifetime doses from 
background radiation. Once again, correction factors for age could be required. 
Part two of this study consists of establishing a dose response curve across a variety of 
acute radiation doses ranging from zero dose to 8.5 Gy (LD90/30) for the rhesus macaques 
(MacVittie, Farese, & Jackson, 2015). Goans et al. conducted a retrospective dose response study 
on 8 humans exposed to a mixed field of gamma rays and neutrons during the criticality accident 
at the Y-12 uranium enrichment facility in 1958 (Goans et. al, 2017). A dose response curve was 
constructed, however there was a small sample size, doses were estimated with dose 
reconstruction models lending to possible error, and the distribution of doses was split into a low 
dose cohort and a high dose cohort versus a spectrum. The limitations of the Goans et. al study 
was mitigated by using well characterized radiation doses to non-human primates, accumulating 
a large sample size, and seeking a spectrum of doses for a more robust dose response curve.  
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Part three of this study establishes a biokinetics and persistence model that illustrates how 
quickly the PPHA morphology manifests and how long PPHAs persist following exposure. In 
previous studies, biokinetics and persistence were briefly studied by Goans et al. Goans et al. 
irradiated non-human primates at the Armed Forces Radiobiology Research Institute (AFRRI) 
using a Co-60 source, and blood smears were taken to investigate how quickly the PPHA 
morphology began to rise in prevalence within the blood (Goans, 2015). Goans et al documented 
an increased frequency of PPHAs within 5 hours post exposure, but a peak prevalence was not 
documented and whether the prevalence persisted at that peak was not investigated. Persistence 
was retrospectively investigated by Goans et al. using the survivors of the Y-12 criticality 
accident, however, with a variety of doses received by the victims of the accident each 
persistence model only has n=1.  
Part three of the study was accomplished using rhesus macaque blood smears taken at 18 
different time points following exposure to a single, well characterized, acute radiation dose of 4 
Gy then evaluated for PPHAs. The goal of evaluating multiple time points for PPHAs post-
exposure is to provide insight into the time for the PPHA morphology to reach peak prevalence, 
and how persistent that prevalence is within the bounds of  available samples (3.1 years post 
exposure).  
The final part of this study consists of analyzing the collected data and extrapolating what 
further studies must be conducted to validate the PPHA morphology as a biomarker and to 
demonstrate that the PPHA assay can be utilized for biodosimetry.  While the models built for 
this project will be more robust than previous studies, shortcomings remain. Future directions 
include analysis of more zero dose rhesus macaques to increase confidence in baseline, 
expansion of the dose response model by adding additional animals to increase a variety of 
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doses, extending the biokinetics model beyond the available 3.1 years of blood smears, and 
increasing frequency of blood smears taken immediately following irradiation to better 
characterize the induction of PPHAs. Additional anticipated areas of research that can be done to 
continue this project are to molecularly characterize the PPHA morphology, investigate other 
means of inducing PPHAs (chemical, viral, dietary, etc..), and investigating the efficacy of 
PPHA assay automation using metasystem microscopes that are currently in use for dicentric 
chromosome analysis.  
 
Definitions of Pertinent Terms 
Biokinetics – The movement of something inside of an organism, or of the organism itself 
(Ellapen & Swanepoel, 2017).  In the context of the PPHA assay, biokinetics describes 
the mobilization of the anomalous neutrophils from the red bone marrow in the context of 
both the peak mobilization and how fast the mobilization reaches that peak in the 
peripheral blood following an irradiation event. 
Prevalence – The proportion of a population that expresses a variable of interest at a specific 
time. The PPHA assay investigates the prevalence of neutrophils that present with the 
PPHA morphology as a percentage.  
Persistence – The continuance in a course of action for a behavior, reaction, or effect despite any 
form of opposition that may be present.  Following the increase in prevalence and 
subsequent peak of PPHAs in the peripheral blood, how long the PPHA morphology 
maintains that peak is investigated as the ‘persistence’ of the morphology.  
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Pelger-Huët anomalies (PHA) – a bilobed neutrophil that has variable shapes and sizes of the 
two lobes but is connected by a very thin bridge of nuclear material, often presenting with 
a dumbbell shape. Originates from a mutation on chromosome-1 that leads to a defect in 
the lamin-B receptor (Colella, 2012).  
Pseudo Pelger-Huët anomalies (PPHA) – Presents with the same morphology as the PHA but is 
not caused by a mutation on chromosome-1. PPHAs are induced anomalies, by 
interaction of radiation with an unknown portion of the generation of granulocytes. The 
PPHA appears in all granulocytes (neutrophils, eosinophils, & basophils); however, the 
neutrophil is the most abundant white blood cell in peripheral blood making it the best 
choice for use in the PPHA assay (Colella, 2012).  
Hematopoietic Stem Cells (HSC) – The progenitor cell that resides in the red bone marrow and 
can differentiate into all cells of the hematopoietic system (Spangrude, Heimfeld, & 
Weissman, 1988).  Differentiation is determined by growth factors that bind to 
transmembrane receptors and induce intracellular pathways.  
Neutrophils – A granulocyte that is a part of the innate immune system and can induce oxidative 
environments in bacterially infected tissues.  The neutrophil is the most abundant white 
blood cell in the peripheral blood and contains a segmented nucleus (King, Toler & 
Woodell-May, 2018).  The PPHA and PHA are both anomalous morphologies of the 
neutrophil. 
Gray – A unit of measure that denotes radiation absorbed dose under the international system of 
units.   The base units for a Gray are Joules per kg (ICRU Publication No. 51, 1993), 
which is energy deposited per unit mass.  Gray is the unit of measure used for irradiation 
protocols for the rhesus macaques in this study.  
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Triage – a process by which severity of injuries imparted on patients is assessed and a priority is 
place upon them for treatment based on their physical condition and the likelihood of 
survival with and without treatment.  Early dose assessment is an important factor in 
triage for radiological accidents, and biodosimetry methodologies are one of many tools 
for assessment.  
 
Ionizing Radiation, Biological Effects, & Relevant Real-World Cases 
 Pseudo Pelger-Huët anomalies present as an induced anomaly under multiple exposure 
scenarios and from multiple modalities of radiation warranting a brief explanation of the 
different types of radiation. Radiation can be placed into two distinct categories, ionizing 
radiation and non-ionizing radiation; both non-ionizing and ionizing radiation can be further 
subdivided into particle and electromagnetic radiation.  Particle radiation includes neutrons, beta 
particles, alpha particles, protons, and heavy charged particles, while electromagnetic waves 
includes X-rays and gamma () rays. Ionization is the basis for biological impacts of radiation, 
and the energy threshold required for ionization to occur is known as the ionization potential. 
Non-ionizing radiation is not capable of ionizing atoms from electromagnetic waves or particles 
because they are below the ionization potential. The deposition of non-ionizing radiation energy 
leads to heating and is not of interest to this study. Ionizing radiation, however, is inherently 
capable of depositing sufficient energy into matter to detach electrons from the atoms it interacts 
with, thereby ionizing that atom.   
 Alpha (α)  particles are ejected from the nucleus and are identical to a helium nucleus, 2 
protons and 2 neutrons. Examples of α-emitters include thorium 232, radium 226, uranium 238, 
and radon 222 (ICRU Publication No. 10b, 1964). Beta (β) particles are also ejected from the 
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nucleus and are either a negatively charged electron or a positively charged positron.  Examples 
of β-emitters include tritium, sulfur-35, strontium-90, and carbon-14 (ICRU Publication No. 10b, 
1964). Heavy charged particles are positively charged nuclei of elements including iron and 
carbon that have been stripped of some or all their orbital electrons. Heavy charged particles are 
most commonly components of space radiation and are a large contributor of dose to space 
exploration and research. X-rays and gamma-rays are high energy electromagnetic waves with 
wavelengths less than 200 nanometers. Both X-rays and gamma-() rays frequently accompany α 
and β particles as they are emitted from a decaying radioactive atom. X-rays and gamma-rays 
differ from one another based on their origin in a decaying atom: X-rays are of orbital origin, 
while gamma-rays are of nuclear origin. Examples of wave radiation emitters include cobalt-60, 
barium-137m, and manmade sources of X-rays such as the accelerators used to irradiate the 
animals in this project (ICRU Publication No. 10b, 1964).  Lastly, neutrons are commonly a 
product of a fission reaction in the core of a nuclear reactor.  Fission occurs when a neutron 
impacts the nucleus of a fissile atom and the nucleus splits into two fission products generally 
with an atomic number of approximately 92 and 135 (ICRU Publication No. 10b, 1964).  
Examples of fissile radionuclides include uranium-235 and plutonium 239.   
 As previously stated, the basis for biological impacts of ionizing radiation is the 
ionization of matter.  On a cellular and molecular level, ionizing radiation affects the 
functionality of the cell by damaging DNA within the nucleus or impeding other cellular 
functions through oxidative stress. DNA damage can be either direct or indirect ionization of the 
nucleic acid strand.  Direct damage is responsible for approximately 30% of ionizing events 
damaging DNA, while indirect damage is responsible for approximately 70% of DNA ionizing 
events.  Direct damage can occur from either particulates or electromagnetic waves and will pass 
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through the cytoplasm of the cell and impact the structure of DNA directly as the name implies.  
Indirect damage results in the generation of reactive oxygen species (ROS) as the tracks of 
radiation ionize the water molecules in the cytoplasm. Reactive oxygen species include hydrogen 
radicals (H•), hydroxyl radicals (OH•), and free electrons (e-), which can diffuse through the 
cytoplasm and cause ionizing events that will damage the DNA strand (Alizadeh, Sanz, Garcia, 
& Sanche, 2013).  
 Damage to one cell is often accompanied by damage to many other cells leading to 
visually recognizable tissue damage. Tissue is defined as one or more cell types working 
together for a common function, and damage to tissue is directly proportional to the dose that is 
absorbed by the tissue at low doses, and directly proportional to the square of the dose at high 
doses. Low doses generally result in sub-lethal damage that can be repaired with endogenous 
DNA repair mechanism but can still produce double strand DNA breaks.  Higher doses can result 
in double strand breaks of DNA from clustered ionizing events that can result in mitotic cell 
death or apoptotic cell death.  If this cell death is widespread due to a large dose or a 
concentrated field of irradiation it can result in deterministic effects like acute radiation 
syndrome and/or stochastic effects such as cancers. Currently the PPHA morphology can best be 
described as a stochastic effect because they have a baseline prevalence, and the possibility of 
their occurrence increases with increased radiation dose.  
  
The Purpose of Biodosimetry and Current Methods 
Biodosimetry is the science of using a biological, physiological, or chemical marker for 
the purposes of reconstructing a dose of ionizing radiation that was imparted on human tissues. 
While there are many techniques in use today the immense variety of scenarios in which people 
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can be exposed renders no one assay as the best method, let alone a standalone assay.  Many 
factors to include detection limits, number of patients, other hazards to life and well-being of 
both patients and the caregivers, accessibility to necessary laboratory equipment, and cost all 
impact what assay is best for a situation.  Emergency preparedness and research seeking to 
improve preparedness for radiological incidents or a nuclear disaster call for the ability to 
perform a number of different assays to include but not limited to electron paramagnetic 
resonance, dicentric chromosome analysis, gamma-() H2AX foci analysis, micronuclei, 
lymphocyte depletion, premature chromosome condensation (PCC), time to emesis following 
exposure, and gene expression.  Below is a short description of each of the preceding methods of 
biodosimetry, their strengths associated with that assay, limitations of the assays, and the 
detection limits (Table 1).  
Electron Paramagnetic Resonance (EPR) – EPR has been widely used for the detection of free 
radicals and transition metals in many industries.  It is used as a biodosimeter by 
detecting free radicals that are produced when radiation interacts with biological tissue.  
Free radicals produced in the aqueous environment of the cell only last in the nanosecond 
range.  Free radicals produced in calcified tissue such as bone and teeth can trap the free 
radicals for much longer on a scale of 108 years (Swartz et. al, 2007).  The EPR signal 
has also been shown to be present in the keratin fibers of fingernails but degrades with in 
several weeks (Symons, et al., 1995). EPR has been used in retrospective studies of 
victims of Nagasaki, Hiroshima, and Chernobyl.  
Dicentric Chromosome Assay (DCA) – Dicentric chromosome analysis is conducted by 
culturing peripheral blood with the isolation of lymphocytes. Next, lymphocytes are 
stimulated to divide while adding a spindle fiber block to arrest the cells in metaphase 
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(Johnson & Rao, 1970).  The result is a chromosome spread where dicentrics can be 
quantified to assess a dose.  DCA is capable of being extremely accurate because of low 
background rates of dicentrics in humans, and it has been conducted on hundreds of 
humans allowing for a well characterized dose response curve. In a non-emergency 
setting the goal is to score between 500 and 1000 metaphase spreads, but in a triage 
situation this is far too time consuming.  For emergency situations, the requirement is 
between 50 and 100 metaphase spreads to keep the standard deviation between 0.5 and 
1.0 Gy (Sullivan, et al., 2013).  Persistence is described as reliable between three and six 
months, when it becomes more reliable to quantify translocations via Fluorescent In -Situ 
Hybridization.  
Gamma H2AX foci Assays (γ-H2AX) – A process of quantifying the γ-H2AX protein through 
either flow cytometry or fluorescent microscopy.  The γ-H2AX protein accumulates at 
the site of double strand breaks and becomes phosphorylated in the process of DNA 
repair (Rogakau et al, 1998).  The protein degrades rapidly so it is advised that blood be 
drawn and analyzed within 30 minutes to one-hour post exposure, but not to exceed one 
to two days (Rothkamm & Horn, 2009).  
Cytokinesis Block (micronuclei) – A micronucleus is formed when a segment of a chromosome 
that has been broken via a double strand break fails to be incorporated into the daughter 
nuclei (Heddle, 1973).  This is informative of a radiation dose because the frequency of 
double strand breaks is proportional to the radiation dose imparted on the individual. The 
result is a much smaller, but separate nucleus that remains with in the cytoplasm of a 
daughter cell.  The type of chromosome aberration is persistent with a half-life of one 
year.  The samples are cultured in a similar manner as dicentric analysis although they do 
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not include a metaphase cell cycle block.  The samples are then fixed and stained for 
viewing under light microscopy.  The recommended quantity to count is 1000 cells, but 
under triage situation as little as 200 could be counted in under 20 minutes (AFRRI, 
2010). 
Lymphocyte Depletion – Often referred to as a complete blood count (CBC) with differential, 
this is the method of estimating dose to a victim of an acute exposure to radiation 
(Guskova et al, 1988).  This is informative of a radiation dose because following an acute 
exposure there are characteristic changes in the whole blood count that can be correlated 
with radiation dose estimates. The blood is smeared on a glass microscope slide, stained, 
and observed to find the differential count of neutrophils to lymphocytes.  Often this 
process is done at specialized laboratories such as the Cytogenetic Biodosimetry 
Laboratory in Oak Ridge, TN.  Blood needs to be drawn within 12 hours of exposure due 
to the short lifespan of granulocytes in the blood.  The relative differential can fall of f 
exponentially after 12 hours (Goans, 1997).  
Premature Chromosome Condensation (PCC) – Is a method of viewing chromosomal aberrations 
without having to force lymphocytes through mitosis. The interphase lymphocytes are 
treated with chemical agents or mitotic Chinese hamster ovary (CHO) cells.  The result is 
a condensation of interphase chromatin into chromosomes (in G1 or G2 cells) 
(Nishimoto, Eilen, & Basilico, 1978). The resulting visible aberrations to include 
dicentrics, translocations, and rings can be measured (in G2 cells).  Double strand breaks 
are counted among the condensed chromatin and their frequency can be used to estimate 
a radiation dose. The same automated metaphase finder that is used in dicentric analysis 
can be used to analyze these data (Lindholm, et al., 2010).  When PCC and DCA are 
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compared the same source found that DCA is best for exposures under 6 Gy, while PCC 
is best for exposures over 6 Gy.  
Time to Emesis- A crude method of biodosimetry is estimating the magnitude of dose imparted 
on the individual by measuring the time from the irradiation incident to the time when 
emesis begins.  Early data produced indicates that if the patient were to begin vomiting in 
less than 2 hours following the irradiation incident the whole-body radiation dose can be 
estimated at greater than 3 Gy, and if the time to vomiting is less than 1 hour the whole 
body radiation dose can be estimated at greater than 4 Gy (Demidenko, Williams, & 
Swartz, 2009).  The International Atomic Energy Agency (IAEA) has published a 
reference table of similar values. Emesis 2 hours post Irradiation incident equates to a 2  
Gy or less whole-body dose, and emesis between 1 and 2 hours post irradiation incident 
equates to a 2-4 Gy whole body dose (IAEA Safety Report Series no. 2). 
Gene Expression – Gene expression is the systematic measurement of gene pathways that have 
been shown to be particularly radiosensitive in peripheral blood.  Some examples include 
genes in the injury repair pathway and p53-dependent DNA repair pathway (Paul & 
Amundson, 2008). Techniques including polymerized chain reaction (PCR) and nuclease 
protection assay (NPA) have been used to form a data base in which gene sets taken from 
exposure victims can be compared to determine an exposure estimate.  Samples should be 
taken from exposure victims within 48-72 hours following the incident because gene 
expression techniques become invalid after a week (Meadow et al., 2008).  
Many of these biodosimetry assays require immense logistical requirements which 
highlights the need for methods that are low cost, quick, and accurate.  The PPHA assay 
demonstrates the potential to fill these needs. It can be low cost because the necessary equipment 
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includes glass slides, a nuclear stain, coverslips, and a light microscope; all of which are 
common laboratory equipment.  It can be quick because the microscope slide only takes a trained 
technician less than 15 minutes to evaluate, and in fact the longest portion of the assay is fixing 
and staining the blood sample on the slide. Lastly, the PPHA assay can also be accurate if  the 
exact mechanism of origin is discovered and a system of repeated laboratory irradiation and 
evaluation of samples can occur to narrow down detection limits, much like what has been done 
with dicentric chromosome analysis. A list of the biodosimetry methods, associated dose 
limitations, and the location of original research validating them can be referenced in Table 1.  
 




The Hematopoietic System and Neutrophil Development 
 Understanding of the PPHA requires a working knowledge of the hematopoietic system 
for which the PPHA is a part (see Appendix D for a flow chart of the process). All blood cells, 
including white and red, originate from hematopoietic stem cells in the bone marrow.  There are 
two types of hematopoietic stem cells that exist in the bone marrow; long-term hematopoietic 
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stem cells that are self-renewing adult stem cells and short-term hematopoietic stem cells that 
differentiate into progenitor cells.  Progenitor cells consist of the common lymphoid progenitor 
that give rise to T-lymphocytes and B-lymphocytes, while the common myeloid progenitor will 
give rise to red blood cells, megakaryocytes, monocytes, and granulocytes.  Differentiation of 
stem cells is based on the introduction of different chemokines that bind to the cell and induce 
selection of a pathway.  The PPHA is an anomalous neutrophil so the specific details of 
neutrophil development will be expanded upon, but the development of other types of cells will 
be briefly discussed.  
 If a sample of whole blood is placed in a cell preparation tube (CPT) and centrifuged it 
will separate into three distinct layers of tissue.  The bottom layer is known as the hematocrit and 
comprises roughly 45% of blood volume. The bottom layer consists of a red blood cells that are 
small bi-concave discs containing no nucleus, numerous iron rich molecules known as 
hemoglobin, but no cellular protein or lipid synthesis machinery.  The purpose of a red blood 
cells is to carry oxygen molecules to the tissues to be used in the production of adenosine 
triphosphate (ATP) in mitochondria. Since red blood cells contain no nucleus or protein 
manufacturing machinery the life span of these cells is normally 90-120 days. Red blood cells 
are the most abundant cell type in peripheral blood and can be seen in every image of a 
peripheral blood smear in this document. The upper layer of centrifuged blood is known as the 
blood plasma and comprises roughly 55% of the blood volume. Blood plasma is a liquid solution 
in which both white and red blood cells are suspended when the blood is mixed.  The plasma 
consists of water with dissolved salts called electrolytes and proteins. The middle layer of the 
centrifuged blood is known as the buffy coat and comprises less than 1% of the total blood 
volume (Garraud & Tissot, 2018).  The buffy coat contains all the white blood cells and platelets.  
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The plasma and buffy coat together contain the components of the immune system. The PPHAs 
and all other nucleated cellular components will be in the buffy coat.  While white blood cells is 
a term that encompasses many different types of cells, platelets are the product of a cell known 
as a megakaryocyte that fractures into hundreds to thousands of membrane bound bags 
containing granules and cytoplasm (Garraud & Tissot, 2018). In addition to erythrocytes, blood 
platelets are visible in every cell image in this document, and they appear as small purple circles 




Figure 1. Red blood cells (A), platelets(B), and a PPHA cell (C) from Macaque 1905, blood 







 The term hematopoiesis describes a process in the human body that contributes to the 
formation of blood. The process of hematopoiesis, the generation of blood, begins in the bone 
marrow with the hematopoietic stem cell (HSC) and the stromal support cells (Appendix D).  
HSCs can differentiate into erythrocytes (red blood cells), leukocytes (white blood cells), and 
platelets, and the differentiation of the HSC into one of these components is dependent upon 
which growth factors it receives.  For example, if the body requires more red blood cells the 
kidney will release a molecule known as erythropoietin in response to low blood oxygen levels 
and when it binds to progeny of the HSC it will begin the process of erythropoiesis and at that 
point it is destined to become an erythrocyte.   
 The HSC is a pluripotent stem cell that further differentiates into two stem cell progeny, 
which ultimately further differentiate into all cellular components of the blood. A flow chart of 
HSC differentiation into all components of blood can be seen in Appendix D.  The two stem cell 
progeny lines are the myeloid stem cells and the lymphoid stem cells.  The myeloid stem cell 
undergoes one of three processes, erythropoiesis to generate red blood cells, thrombopoiesis to 
generate platelets, or leukopoiesis to generate cells of innate and adaptive immunity.  The 
myeloid stem cell gives rise to several cells of importance that must be differentiated in the 
performance of a peripheral blood smear evaluation.  The first cell type that the myeloid stem 
cell can differentiate into is the neutrophil.  The neutrophil is a granulocyte and is the most 
abundant nucleated cell in the peripheral blood (Figure 2). Granulocytes migrate from the bone 
marrow and circulate in the blood where they eventually leave the blood vascular compartment 
and enter damaged tissue where they perform their function.  Neutrophils will phagocytose 
foreign bodies and secrete oxidative materials such as hydrogen peroxide and free electrons.  
Neutrophils are polymorphonucleated and generally have between 3 and 7 lobes in their nucleus. 
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Neutrophils with less than 3 lobes are considered hypo-segmented and those with more than 5 
are considered hyper-segmented. Both hypo- and hyper- segmented nuclei are abnormalities, 
with the bilobed nature of PPHAs being an anomaly. The neutrophil can be distinguished from 
the other granulocytes by its lack of darkly colored or reddish granules in the cytoplasm.  While 
they do in fact have granules in the cytoplasm, they are full of molecules that are not visible 
under light microscopy, so they appear translucent.  An immature form of neutrophil can be 
normally viewed in the peripheral blood and is called a band cell.  The band cell has the 
beginning of the indentation that will lead to segmentation and has a horseshoe like appearance. 
A normal neutrophil can be seen in Figure 2. 
  




With the introduction of interleukin-3 or interleukin-5 the myeloid stem cell will begin to 
differentiate into a basophil or an eosinophil, respectively.  With interleukin-3 and the addition of 
granulocyte/macrophage-colony stimulating factor (G/M-CSF) the myeloid stem cell will 
differentiate into a granulocyte/macrophage progenitor cell (GMP).  Additional introduction of 
granulocyte colony stimulating factor (G-CSF) or macrophage-colony stimulating factor (M-
CSF) the GMP will differentiate into a neutrophil or a monocyte, respectively (Lieschke & 
Burgess, 1992). Upon differentiating into a neutrophil, the cell exists in an inactive form until 
activated by chemokines from the site of damaged tissue in the body.  
 When tissue is damaged it releases chemokines such as interleukin-23 (IL-23) and 
interferon gamma into the blood stream.  Circulating neutrophils, once at the site of damaged 
tissue, bind to transmembrane proteins expressed on the apical membrane of the endothelial cells 
called selectins that allow for the neutrophils to attach and exit the blood vascular compartment 
via diapedesis.  Once in the interstitial space, neutrophils have the capability of following a 
chemical gradient of chemokines in a near amoeboid manner using pseudopodia. The neutrophil 
proceeds to destroy micro-organisms via phagocytosis, degranulation, and neutrophil 
extracellular traps.  Neutrophils contain granules that are filled with peroxides, alkaline 
phosphates, lysosomal proteins, proteases, and collagenases.  Neutrophils will excrete these 
granules into the extra cellular space, as well as fuse the granules with the phagosome that is 
produced following phagocytosis of the microorganism. Neutrophil extracellular traps consist of 
the neutrophil excreting an extracellular matrix made of DNA and granule proteins that can 
ensnare microbes and inhibit the spread of infection and limit damage to the local tissue 
(Brinkmann, 2004).  Neutrophils are thought to have a lifespan of approximately 8 hours in the 
blood stream, and the bone marrow is thought to produce upwards of 100 billion neutrophils  per 
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day.  Upon completion of their anti-microbial task the neutrophils are endocytosed by other 
phagocytic cells (dendritic cells and macrophages).  
The concentration of mature neutrophils in the peripheral blood is regulated by a 
feedback loop generated by dendritic cells and macrophages.  The stimulus for upregulation of 
granulopoiesis is given by the release of IL-23 from macrophages and dendritic cells.  In turn, 
IL-23 stimulates secretion of interleukin-17 (IL-17) from T-cells, and IL-17 increases the levels 
of G-CSF.  The subsequent flood of neutrophils to the peripheral blood and their phagocytic 
behavior reduces the production of IL-23, therefore reduces IL-17 and G-CSF, ultimately down-
regulating granulopoiesis in a negative feedback type fashion (Vietinghoff & Ley, 2008). A 
diagram showing the negative feedback loop in granulopoiesis can be seen in Appendix D.  
The second cell type into which myeloid stem cells differentiate is an eosinophil, a 
polymorphonucleated granulocyte whose function is to neutralize parasitic organisms within the 
body. Eosinophils can be distinguished from other cells in a peripheral blood smear by the many 
red granules present in the cell’s cytoplasm and a multi-lobed nucleus. An eosinophil can be seen 




Figure 3: Eosinophil from Macaque 1905, blood smear taken on November 24, 2015. 
 The next type of cell into which myeloid stem cells can differentiate is a monocyte. 
Monocytes have a large nucleus that when stained appears bean-like in shape.  Monocytes are 
the largest of the cells in a peripheral blood smear, but they can be difficult to differentiate them 
from lymphocytes when the nucleus does not have the characteristic bean shape.  Monocytes 
leave the blood vascular compartment through a process called diapedesis and within the tissues 
they mature into a macrophage.  Macrophages are essential to an inflammatory response due to 
their phagocytic nature, and essential to the adaptive immune response due to their ability to 
display antigen fragments on major histocompatibility type 2 receptors for interaction with T-
lymphocytes known as CD4 cells.  A monocyte can be seen on a peripheral blood smear in 




Figure 4. Monocyte from Macaque 1905, blood smear taken on November 24, 2015. 
 The next cell type which myeloid stem cells can differentiate into is a basophil.  
Basophils, along with a histaminergic cell called a mast cell, helps initiate the inflammatory 
response.  Basophil specifically will secrete molecules that are chemotactic towards eosinophils. 
Basophils create a chemical gradient that draws eosinophils to the site of inflammation.  
Basophils also secrete molecules that are broncho-constrictive.  It is thought that basophils are 
partly responsible for initiating and maintaining an allergic response (Siracusa, Kim, Spergel, & 
Artis, 2013).  Basophils are the rarest cell type in a peripheral blood smear and can be 
distinguished by its lobular nucleus and a multitude of darkly colored secretory granules. A 
basophil can be seen in a peripheral blood smear in Figure 5.   
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Figure 5. Basophil from Macaque 1905, blood smear taken on November 24, 2015. 
In the lymphoid stem cell line, lymphoid stem cells undergo leukopoiesis to differentiate 
into B-lymphocytes and T-lymphocytes.  B and T lymphocytes are responsible for a person’s 
adaptive immunity. A lymphocyte is one of many cells that can be seen in a peripheral blood 
smear. When stained with Giemsa, lymphocytes appear to have a large round nucleus that takes 
up most of the cell’s cytoplasm.  B-lymphocytes are local to germinal regions in lymph nodes, 
gut associated lymphatic tissue, and the white pulp of the kidney. Any lymphocytes present in 
the peripheral blood are assumed to be T-lymphocytes. A lymphocyte from a peripheral blood 




Figure 6: Lymphocyte from Macaque 1905, blood smear taken on November 24, 2015 
 
 A diagram of the hematopoietic stem cell differentiation including cell types and growth 
factors that induce the differentiation can be seen in Appendix D.  
 
The Pseudo Pelger-Huët Anomaly: Morphology and Suspected Origin 
Historically, there is a distinction between the Pelger-Huët Anomaly (PHA) and the 
pseudo Pelger-Huët anomaly (PPHA).  The PHA can be observed in neutrophils, and any other 
granulocyte (neutrophils, eosinophils, and basophils).  PPHAs are only quantified in neutrophils 
because neutrophils are the most abundant white blood cell in the peripheral blood. Counting the 
PPHA morphology in other granulocytes would be inefficient due to their low numbers in 
peripheral blood. PHAs are naturally occurring and were first described in 1928 by the German 
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physician, Karl Pelger, and were believed to be a sign of poor prognosis for tuberculosis (Pelger, 
1928).  However, in 1932 G.J Huët discovered PHAs were linked to an autosomal dominant 
mutation on the long arm of chromosome 1 (Huët, 1932).  The mutation was in a gene that 
encodes for the lamin-B receptor, which is a membrane associated protein embedded in the inner 
nuclear membrane of the nuclear envelope.  The lamin-B receptor has two functions that can be 
described by their location on the protein. The carboxyl terminus performs C14 sterol reductase 
activity which involves the breaking of carbon double bonds in cholesterol synthesis, while the 
amine terminus of the lamin-B receptor binds to an intermediate filament called lamin-B.  
Lamin-B in turn binds to the chromatin and provides structure to both the chromatin and the 
nucleoplasm (Holmer, Pezham, & Worman, 1998). The structure of the nucleus is incredibly 
important to granulocytes because a hyper-segmented nucleus makes it much easier for these 
cells to exit the blood vascular compartment via diapedesis.  The structure of the nucleus also 
allows for ease in movement throughout tissues as the cell is migrating to areas undergoing the 
inflammation response (Colella, 2012). An image of the lamin-B receptor with the sterol 





Figure 7. Structure of the lamin-B receptor (Hayes, 2018). 
 
 While the Pelger-Huët anomaly and pseudo Pelger-Huët anomalies can be seen in any 
granulocyte, PPHAs are only quantified in neutrophils because they are the most abundant 
leukocyte in peripheral blood. If the cell morphology is induced from an outside stimulus, such 
as an exposure to a toxin or ionizing radiation the cells are pseudo Pelger-Huët anomalies 
(PPHAs).  PHAs and PPHAs are distinguishable from other neutrophils in a peripheral blood 
smear by two factors.  The nucleus of the PPHA is bilobular with two lobes that can take on a 
number of different shapes and sizes, and the two segments are connected by a very thin mitotic 
bridge (Goans, Iddins, Ossetrova, Ney, & Daniak, 2015). While many of the images of PPHAs in 
this document display a perfectly round to bean-like structure of the two lobes, many of them 
present with an obscure shape that can be somewhat misleading to the evaluator. Several 




   
 
Figure 8. Examples of pseudo Pelger-Huët anomalies, and their various shapes of the two lobes. 
The thin bridge connecting the two lobes can be seen in each image (black arrow). 
 
 Some confusion can be experience when differentiating PPHAs and immature 
neutrophils.  Immature neutrophils remain in the bone marrow through interactions with the 
chemokine CXCL12 and its receptor CSCR4 (Vietinghoff & Ley, 2008).  Immature neutrophils 
are rarely found in the peripheral blood but can escape the bone marrow during an inflammation 
response. Immature neutrophils in peripheral blood have a band-like morphology as opposed to a 
multilobed nucleus.  In addition, if immature neutrophils enter the peripheral blood in a hypo-
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segmented form they can be differentiated from PPHAs by the presence of Dohle bodies, 
fragments of the cells endoplasmic reticulum lost in development.  It is possible that progenitor 
cells giving rise to granulocytes are impacted by radiation dose to produce the PPHA 
morphology.  Progenitor cells are not terminally differentiated therefore they are more 
radiosensitive than the post-mitotic neutrophils.  In addition, other granulocytes (basophils and 
eosinophils) often present with a bilobed morphology indicating that a common ancestor is being 
impacted. As previously stated, basophils and eosinophils are far less common in the peripheral 
blood under normal physiological conditions, so basophils and eosinophils are not informative 
biomarkers of radiation dose. A PPHA with an obscure shape to its two lobes and the most 
common morphology for a neutrophil can be seen in Figure 9. 
   
Figure 9. Example of a normal neutrophil (A), next to a Pseudo Pelger-Huët anomaly (B), from 





 Radiation could impact neutrophil progenitor cells in several possible ways to induce the 
PPHA morphology.  First, the lamin-b receptor could be impacted either through direct 
interaction with the radiation or mutations generated on chromosome 1.  Direct radiation 
interaction on chromosome 1 is unlikely since the lamin-b receptor is a small target for the 
radiation compared to the genome, and mutations would take longer to manifest than the cells 
have taken to experimentally be expressed in nonhuman primates (Goans, 2017). Second, the 
direct or indirect interaction of the radiation energy absorbed could result in DNA DSBs, 
impacting the stability of neutrophil progenitor cell’s genome, and inhibiting the ability of the 
nucleus to fully segment.  Neutrophils are the most abundant white blood cells in the peripheral 
blood and are therefore the largest target amongst nucleated blood cells, so it is possible that 
neutrophils would be most commonly expressing a bilobed morphology due to hypothesized 
mechanisms.  Identifying the composition of the bridge between the lobes of the PPHA (Figure 
8) could help determine the cause of the morphology. The PPHA bridge could be a hypo-
segmentation of the nucleus. Alternatively, the PPHA bridge could represent a failure to 
complete cytokinesis during the cell cycle of the neutrophil progenitor cells due to a dicentric 
chromosome being stretched between the two lobes.   
 
The Pseudo Pelger-Huët Anomaly as a Biodosimeter in Previous Research 
There are several examples of PPHAs being used in research as potential biomarkers of 
radiation dose; here they will be summarized individually, and conclusions highlighted. 
Japanese wild boar and large Japanese field mice (2017)– Wild Boar (Sus scrofa leucomystax) 
and large Japanese field mice (Apodemus Speciosus) were used as sentinel species of 
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opportunity from within the exclusion zone of the Fukushima Daiichi nuclear disaster 
area. The wild boar and mice were chronically exposed to low dose environmental 
radiation because of the deposition of long-lived fission fragments and fission products in 
the environment surrounding the Fukushima Dai-ichi nuclear reactors.  Free-ranging wild 
boar and field mice were live captured and lifetime dose estimations calculated using 
muscle radiocesium burden and external dose estimations combined with an observed 
effective half-life for contamination.  The large Japanese field mice (n=20) were live 
captured in areas with ambient dose rates ranging from 0.1 microSeieverts/hour (μSv/h) 
to 50 mSv/hr and no PPHA morphologies were observed in their peripheral blood. 
Japanese wild boar (n=38) were live captured in areas with ambient dose rates ranging 
from 0.1 μSv/h to 25 mSv/h and a dose response curve was constructed (Hayes, 2018).  A 
linear relationship between estimated lifetime dose and PPHA frequencies in peripheral 
blood was found. Limitations of this study include estimated radiation doses, unknown 
environmental factors that impact the animal’s health, and unknown additional exposures 
besides radiation. 
South African Bats (2001) – A study conducted in South Africa utilized a resident population of 
bats (Chiroptera) in an abandoned mine.  The background radiation within the mine was 
orders of magnitude above normal background because the ore inside contained high 
concentrations of a mineral known as monazite. Monazite contains an abundance of 
thorium-232 and its progeny.  The bats were divided into 3 populations: controls that 
were exposed to normal terrestrial background radiation, a low dose area of the monazite 
mine with dose rates of 20 μSv/h, and a high dose area of the mine with dose rates of 100 
μSv/h.  Peripheral blood smears were taken from the bats, among other samples and 
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whole blood counts were performed. Only 100 total cells were counted across all types of 
white blood cells and within that, the percentage of neutrophils that displayed the PPHA 
morphology was calculated to be 0.27% in the controls, 12.67% in the low dose areas, 
and 22.66% in the high dose areas (Meehan, 2001).  Limitations in this study include 
estimated radiation doses, unknown environmental factors that could impact health, and 
an exceptionally low count of neutrophils from which the prevalence of PPHAs was 
calculated.  
Y-12 criticality accident victims, 2015 – The Radiation Emergency Assistance Center/Training 
Site (REAC/TS) conducted a retrospective study of the 1958 Y-12 criticality accident.  
The accident occurred when a group of radiation workers were pouring uranyl nitrate 
solution used in the extraction of enriched uranium from solid waste, into a 55-gallon 
drum believed to be empty.  The barrel contained water, and the uranyl nitrate containing 
approximately 2.1 kg of uranium 235 went critical (Mclaughlin, Monahan, Pruvost, 
Frolov, Ryazanov, & Sviridox, 2000).  Eight workers received doses ranging from 0.288 
Sv to 4.61 Sv (28.8 to 461 rem).  Archived slides taken from the victims at the time of the 
accident and several years following were obtained by REAC/TS and were evaluated by 
counting 300 neutrophils and calculating the percentage of cells that had the PPHA 
morphology. The exposures that occurred from the Y-12 criticality accident were 
separated into 2 cohorts, high dose cohort with n=5 and a low dose cohort with n=3.   
Thirteen percent PPHAs were found in the high dose cohort, 6.8% PPHAs in the low 
dose cohort, and 3.6% PPHA background in the control group (Goans, Iddins, Ossetrova, 
Ney, & Daniak, 2015). Limitations in this study include estimated radiation doses, small 
sample size, and an unevenly distributed spectrum of doses.  
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Radium watch dial painters, 2018 – REAC/TS conducted another retrospective biodosimetry 
study on the radium watch dial painters from the first half of the 20 th century.  Radium 
was a commonly used material for creating illuminated dials for watch faces and airplane 
instrumentation.  Radium is a long-lived radionuclide that is a biological analog for 
calcium, resulting in bone deposition of the nuclide. Prior to the abolishment of radium 
dial painting in 1955, dial painters would maintain a fine tip on paint brushes by wetting 
the brush with their mouths and thus ingesting radium.  Archived blood slides from 166 
dial painters with bone marrow doses ranging from 1.5-6,750 mGy were evaluated by 
REAC/TS (Goans, Toohey, Iddins, Mccomish, Tolmachev, & Dainiak, 2018).  The 
resulting data displayed a sigmoidal relationship between bone marrow dose and PPHA 
prevalence.  Limitation to this study include estimated radiation doses. 
Non-human Primates 2016– The Armed Forces Radiobiology Research Institute (AFFRI) 
exposed 10 Rhesus macaques to whole body irradiation (1.0, 3.5, 5.0, 6.5, and 8.5 Gy) 
using a Cobalt-60 source at a dose rate of 600 mGy min-1, with 2 macaques at each dose 
point.  Each animal served as its own control and two additional macaques were used as 
true controls for the experiment. Blood smears were taken prior to irradiation and 
continued to be taken post irradiation with the first one at 5 hours post and the last at 60 
days.  A linear dose response was found, but with no statistical difference between the 1 
Gy macaques and the 0 Gy macaques. Increased frequencies of PPHAs in peripheral 
blood was observed at 5 hours post irradiation, and peaked several days following.  
PPHAs remained at an increased level through the end of the 60-day experiment 
(Ossetrova et al. 2016).  Limitations to this experiment include a small samples size in 
each dose cohort and a short period of observation for the persistence of PPHAs.  
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PHAs in dogs, rabbits, and cats in veterinary literature various dates (Supuka & Parkanyl, 2014 
& Vale, Tomaz, Sousa, & Soto-Blanco, 2011)- PHAs have been reported in many 
animals in veterinary journals as genetic disorders much like humans. Animals were 
excluded from being considered to have PHAs if the animals had any infectious diseases, 
neoplastic diseases, or drug exposures because those were factors thought to induce 
PPHAs in the peripheral blood (Latimer, Rakich, & Thompson, 1985). Radiation was not 
mentioned as a source of PPHAs in these studies, however several other sources of 
PPHAs illustrate the possibility of confounding variables influencing the prevalence of 
PPHAs.  
 
Rhesus Macaques: Species Information and Justification of Use in This Study 
Rhesus Macaques (Macaca mulatta) are a small to medium sized non-human primate 
with an average weight of 7.7 kg (17 pounds) for males and 5.4 kg (12 pounds) for females, an 
average height of 53.3 cm (21 inches), and an average lifespan of 25 years. They are the most 
widespread species of non-human primates geographically on the planet with a natural home 
range in Asia from Afghanistan to the eastern shores of Vietnam and China.  The animals are 
remarkably adaptable to a variety of climates, altitudes, and terrains throughout this entire 
region. The animals have even thrived in areas like coastal islands off the coast of Florida where 
small zoos were destroyed in hurricanes and the animals were free to roam.  Lastly, these 
animals have an immense population in the wild that results in them being listed as ‘least 
concern’ for their conservation status (Singh, Kumar, & Kumara, 2020). 
Their large populations, no conservation concerns, ease of acquisition, and most 
importantly their similarity to humans, both anatomically and physiologically, causes the rhesus 
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macaques to be a common non-human primate used in scientific research. More importantly the 
animals are an excellent model for translational research, and multiple studies have been 
conducted utilizing this species throughout history ranging from psychological research to 
radiation research. Specifically, the blood physiology is identical to humans making the animals 
a perfect model for researching the PPHA morphology (Yu, et. al, 2019). 
Regardless of the type of research macaques need a place to live out their lives once 
projects are concluded.  This necessitates facilities like, in the Section on Comparative Medicine, 
located at the Thomas B Clarkson Campus in Winston-Salem, North Carolina where macaques 
and other non-human primate species can reside for the remainder of their lives.  Rhesus 
macaques used in this study were all residents, or former residents, of the Wake Forest School of 
Medicine, Department of Comparative Medicine.  While there, the animals are housed in large 
facilities inside enclosures that have stainless steel walls that are open from floor to ceiling for 
the macaques to move around freely on a multitude of platforms and ropes intended to keep the 
animals entertained. The cages are built side by side with the cage doors facing the interior 
walkway of the buildings which provides access to the animals by handlers for feeding, 
veterinary care, and cage cleaning. Macaques are inherently social animals, so two animals are 
kept per cage to promote pair bonding and reduce stress to the animal that would be induced by 
solidarity. While social, the macaques are also highly territorial, so the walls separating the cages 
are solid walls which prevents direct interaction between neighboring cages, therefore mitigating 
stress to the animal. Lastly, each enclosure has access to an outside enclosure that is only 
accessible by the two animals in the one enclosure.  Rhesus macaques that are residing at the 
Wake Forest School of Medicine, Department of Comparative Medicine, in the Section on 
Comparative Medicine, located at the Thomas B Clarkson Campus in Winston-Salem, North 
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Carolina can be seen below in Figure 10 (see written permission for use of these images is in 
Appendix E).  
 
Figure 10. Rhesus Macaques, Photos courtesy of the Wake Forest School of Medicine, 



















 This study was approved by the IACUC of Colorado State University on December 20, 
2019 with a Colorado State University IACUC Inter-Institutional Agreement with the Wake 
Forest School of Medicine, Department of Comparative Medicine, in the Section on 
Comparative Medicine, located at the Thomas B Clarkson Campus in Winston-Salem, North 
Carolina (see Appendix A). Animal handling, care, and samples being provided by Wake Forest 
School of Medicine were under the IACUC of the providing institution themselves (see 
Appendix B). Furthermore, safe handling and occupational hazard associated with non-human 
primates were clearly communicated and understood by the receiving institution and consent to 
handling samples was demonstrated by signing an occupational safety and health zoonotic 
concerns agreement with the Wake Forest School of Medicine (see Appendix C).  
 
Studies Conducted Using Rhesus Macaques Blood Smears 
Three distinct PPHA studies were conducted using the blood smears obtained from Wake 
Forest School of Medicine, Department of Comparative Medicine, in the Section on 
Comparative Medicine, located at the Thomas B Clarkson Campus in Winston-Salem, North 
Carolina: a baseline prevalence of the PPHA morphology in non-irradiated macaques, a dose 
response curve, and a biokinetics/persistence study.  Blood smears used in the study were 
selected from an archive of samples that have been taken as part of periodic wellness testing on 
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the primates at the center.  Samples had been archived at the time that they were taken, and 
undisturbed until the time of this project. There were two distinct cohorts of animals that the 
smears were drawn from, the X-15 and the X-10 cohorts.  X-15 was part of a previous study that 
looked at the impacts of radiation dose on gross blood cell counts over the lifetime of the 
animals, while the X-10 cohort was merely the repository of other rhesus macaques that were 
living or had lived at the facility and their blood smears were taken during annual health 
checkups.  All evaluated macaques from both cohorts were used for the dose response model, the 
4 Gy macaques from the X-15 cohort were used for biokinetics/persistence model, and all 
macaques that received 0 Gy of dose, regardless of which cohort they were a part, were used in 
the calculation of the baseline prevalence. A table of all macaques, the doses they received, the 
cohort from which they were drawn, and of which studies they were a part can be seen in Table 
2. 
Table 2. All rhesus macaques with associated animal IDs, cohort, doses received, and 
which study applies to each.  
   
Studies Conducted (✓= Macaque in Study /  
✗= Macaque not in Study) 
Rhesus Macaque 









1962 X-15 (Group 1) 0 ✓ ✓ ✓ 
1965 X-15 (Group 2) 0 ✓ ✓ ✓ 
1971 X-15 (Group 1) 0 ✓ ✓ ✓ 
1973 X-15 (Group 2) 0 ✓ ✓ ✓ 
1974 X-15 (Group 1) 0 ✓ ✓ ✓ 
1975 X-15 (Group 2) 0 ✓ ✓ ✓ 
1976 X-15 (Group 2) 0 ✓ ✓ ✓ 
1977 X-15 (Group 2) 0 ✓ ✓ ✓ 
1979 X-15 (Group 1) 0 ✓ ✓ ✓ 
1982 X-15 (Group 1) 0 ✓ ✓ ✓ 
1960 X-15 0 ✓ ✓ ✓ 
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1967 X-15 0 ✓ ✓ ✓ 
1968 X-15 0 ✓ ✓ ✓ 
1969 X-15 0 ✓ ✓ ✓ 
1970 X-15 0 ✓ ✓ ✓ 
1972 X-15 0 ✓ ✓ ✓ 
2061 X-10 0 ✓ ✗ ✓ 
2065 X-10 0 ✓ ✗ ✓ 
1962 X-15 (Group 1) 4 ✓ ✓ ✗ 
1965 X-15 (Group 2) 4 ✓ ✓ ✗ 
1971 X-15 (Group 1) 4 ✓ ✓ ✗ 
1973 X-15 (Group 2) 4 ✓ ✓ ✗ 
1974 X-15 (Group 1) 4 ✓ ✓ ✗ 
1975 X-15 (Group 2) 4 ✓ ✓ ✗ 
1976 X-15 (Group 2) 4 ✓ ✓ ✗ 
1977 X-15 (Group 2) 4 ✓ ✓ ✗ 
1979 X-15 (Group 1) 4 ✓ ✓ ✗ 
1982 X-15 (Group 1) 4 ✓ ✓ ✗ 
2058 X-10 4 ✓ ✗ ✗ 
2059 X-10 4 ✓ ✗ ✗ 
2060 X-10 4 ✓ ✗ ✗ 
2062 X-10 4 ✓ ✗ ✗ 
2063 X-10 4 ✓ ✗ ✗ 
2064 X-10 4 ✓ ✗ ✗ 
2067 X-10 4 ✓ ✗ ✗ 
1892 X-10 6.4 ✓ ✗ ✗ 
1884 X-10 6.5 ✓ ✗ ✗ 
1885 X-10 6.5 ✓ ✗ ✗ 
1886 X-10 6.5 ✓ ✗ ✗ 
1904 X-10 6.5 ✓ ✗ ✗ 
1906 X-10 6.5 ✓ ✗ ✗ 
1917 X-10 6.5 ✓ ✗ ✗ 
1919 X-10 6.5 ✓ ✗ ✗ 
2056 X-10 6.5 ✓ ✗ ✗ 
1910 X-10 8 ✓ ✗ ✗ 
2053 X-10 8 ✓ ✗ ✗ 




The baseline prevalence of the PPHA morphology was determined by evaluating 18 
macaques that were non-irradiated.  Six of the X-15 cohort were non-irradiated, while the 10 that 
were irradiated contributed blood smears from prior to their irradiation date.  In total, 16 
macaques contributed blood smears from the X-15 cohort, and 2 additional macaques that were 
non-irradiated were taken from the X-10 cohort.  All values generated were averaged and a 
standard deviation was calculated.  
For the dose response study, samples were chosen based on an arbitrary time frame of 
approximately 200 days post irradiation.  The decision to have a narrow time frame was made 
because the persistence of the PPHA morphology was unknown at the time of selection, so all 
smears needed to be in the same stage of persistence, or lack of persistence. The selection of the 
200-day time frame was simply the availability of macaques with a spectrum of doses from 
which blood smears had been taken. The archive of blood smears consisted of nearly 100 
microscope slide boxes and over 8,100 blood smears, all with relatively no organization scheme.  
Slide boxes were all removed from storage and organized first chronologically in accordance 
with the blood smears that they contained.  The predetermined list of  blood smears at the 200-
day time frame were sorted and placed into a separate slide box brought to Wake Forest from 
Colorado State University and subsequently transported back to Colorado.  Only 27 of the 
original 50 selected blood smears were located.  However, an additional 20 blood smears were 
added from the 4 Gy irradiated macaques in the X-10 cohort for a total samples size of 47 
macaques. Ten blood smears were the pre-irradiation samples, and 10 blood smears were 
approximately 200 days post irradiation. The exact time post irradiation was not known until 
after the completion of the biokinetics/persistence study since it was blinded.  
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For the biokinetics/persistence study, blood smears were taken from the Wake Forest’s 
X-15 cohort.  The cohort consisted of 10 non-irradiated macaques and 10 macaques that were 
irradiated in October 2016 with a 4 Gy dose. Four of the 10 non-irradiated macaques had 
succumbed due to comorbidities and were excluded from this study. The remaining 16 macaques 
(10 irradiated and 6 non-irradiated), all had blood smears taken periodically from 6 days prior to 
irradiation to 1124 days post irradiation totaling 19 time points over 3 years and 1 month.  
Samples were taken on a biweekly basis for the first 2 months, but to minimize effects of 
anesthetizing agents on the health of the animal the time frame between smears was spread out to 
as far as 6 months by the conclusion of the study. The irradiated animals were fixed into 2 
groups that were separated merely by the irradiation date.  Group 1 consisted of macaques 1962, 
1971, 1974, 1979, and 1982, while group 2 consisted of macaques 1965, 1971, 1975, 1976, and 
1977. Irradiation dates were October 16, 2016 and October 23, 2016, respectively. Group 
information can be seen in Table 2.  
 
Irradiation Protocols for Rhesus Macaques  
 The control and irradiated animal samples used for this study were obtained from Wake 
Forest School of Medicine, University of Maryland, University of Illinois, Armed Forces 
Radiobiology Research Institute, Lovelace Respiratory Research Institute, Citox Labs, and 
Primate Products. Irradiated animals received 0 to 8.5 Gy total body radiation under IACUC 
oversight at their prior institution using one of two strategies: (1) linear accelerator-derived 
photons at a nominal mean energy of 2 MeV, delivered at 80 cGy/minute as a split dose given 
half anterior-posterior and half posterior-anterior; or (2) Cobalt 60-derived gamma irradiation 
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delivered simultaneously, bilaterally at 60 cGy/min. These are potentially lethal doses: the LD 
10/30 for rhesus macaques is ~5.5 Gy, the LD 50/30 is ~6.7 Gy, and the LD 90/30 is 8 Gy 
(MacVittie, Farese, Jackson, 2015). Surviving animals were subsequently transferred to Wake 
Forest School of Medicine Center for Comparative Medicine Research for long-term monitoring 
post-radiation. Irradiation methods, supportive care strategies, and acute effects for many 
animals donated to this cohort have been recently reported (Farese, Cohen, Katz, Smith, Jackson, 
Cohen, et al., 2012 & Yu, Lindeblad, Lyubimov, Neri, Smith, Szilagyi, et al., 2015) 
After arrival at Wake Forest, all animals were monitored twice daily by trained veterinary 
technical laboratory staff to assure animal well-being and social stability. Any evidence of illness 
was classified using a nonhuman primate-specific modification of the Children’s Clinical 
Oncology Group toxicity criteria (Uckun FM, Yanishevski Y, Tumer N, Waurzyniak B, 
Messinger Y, Chelstrom LM, et al., 1997). Sick animals were promptly evaluated by one of 
seven institutional veterinarians independent of the research team, two of whom are board-
certified by the American College of Laboratory Animal Medicine. 
Animals consumed a diet of laboratory chow (Purina LabDiet Monkey Diet 5038, 
Richmond, IN, USA) that was supplemented with fresh fruits and vegetables and with water as 
often as necessary or desired by the animal. They were housed socially in indoor-outdoor pens 
whenever possible, or in group cages if necessary, for safe handling or medical care. Care was 
taken to ensure the animals in the groups were compatible. Environmental enrichment, including 
fruits/vegetables, toys, puzzles, climbing and hiding environments, was provided continuously 
on a rotating basis. Behavioral well-being was additionally monitored, and recommendations 
made as needed by an independent behavioral management team. All animals were trained to 
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cooperate in handling procedures, to minimize stress. Sampling was scheduled so that the 
animals were sedated the minimum number of times required for data collection.  
All macaques undergo computed tomography (CT) scans as a part of wellness checkups 
on various intervals.  Animals in the X-10 cohort received CT scans upon arrival at the Wake 
Forest School of Medicine, Department of Comparative medicine, and X-15 animals received 
CT scans in May 2016, April 2018, and March 2020.  The effective dose for the CT scans ranged 
from 9-37 mGy across all macaques. The dose received from the CT was inconsequential 
compared to the animal’s acute doses and so was not considered a significant factor in PPHA 
frequency. 
 
Pseudo Pelger-Huët Anomaly Quantification with Light Microscope 
All blood smears were fixed with methanol, air dried, stained using Giemsa-Wright stain, 
and subsequently air dried again. Slide staining was performed the day of the sample collection, 
and at necropsy in the case of deceased animals, in all cases (see Appendix G and H).  Certain 
slides were presented with a slightly different coloration, and it was determined that the same 
stain was used just at a different concentration.  Coloration differences had no impact on the 
ability to evaluate the slides.   
Blood smears were manually inspected under an Olympus BH-2 light microscope at 40x 
magnification. The slide was placed on the stage and low viscosity Thermo Scientific ResolveTM 
microscope immersion oil was used to maximize clarity of evaluation.  The slide was first 
quickly inspected for clarity of staining, quality of cells, and ultimately the ability to continue 
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with the PPHA analysis. Once the slide was determined to be readable, the neutrophils were 
counted in a sweeping back and forth scan that was systematic in nature to ensure that cells were 
not counted more than once.  A count of neutrophils was kept until a PPHA was encountered. At 
that time, the number of neutrophils counted, including the PPHA, was recorded in a laboratory 
notebook using Arabic numerals. The microscope magnification was then increased to 100x for 
closer inspection of the suspected PPHA. If it was determined to be a PPHA, an image was taken 
using a 12 megapixel Galaxy S8+ smartphone with a Gosky microscope lens smartphone camera 
adapter, and the PPHA was recorded in the laboratory notebook as a hashmark on a different line 
below the neutrophil count.  This process was continued until the cumulative count of 
neutrophils, including PPHAs, reached 300 cells.  To ensure that the gross cell count did not fall 
under or exceed 300, every time the number of neutrophils was recorded, the same number was 
added to a gross count on a calculator. This process was repeated for every blood smear 
evaluated in the exact same fashion to maintain consistency in methodology. Following 
evaluation, slides were removed from the microscope stage and placed face down on a paper 
towel to allow the immersion oil to evaporate overnight.  Once determined to be oil free, the 
slides were removed from the paper towel, and the evaluations were reconciled with the sample 
identification number and recorded on a spreadsheet for later analysis.  
 
Risk of Bias in Analysis, and Steps to Mitigate Bias 
 When evaluating blood smears manually there is an inherent risk of bias by the evaluator 
for considering neutrophils to be PPHAs when they are ultimately not (false positive, type 1 
error). Several steps were taken to mitigate this risk of bias in the analysis and the data produced.  
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For the dose response study, animal IDs were known by the evaluator at the time of evaluation, 
but radiation doses were blinded until after the last animal was evaluated. All cell counts were 
kept in a laboratory notebook and data were not transcribed into a digital spreadsheet for 
evaluation until all relevant slides were evaluated.  The exception to this was the 10 macaques 
that were in the X-10 cohort and were included in the dose response with blood smears prior to 
their irradiation (0 Gy) and blood smears approximately 200 days post irradiation (4 Gy). The 
animals that overlapped between the biokinetics/persistence and the dose response studies were 
not added to the dose response until the biokinetics/persistence was complete.  
 For the biokinetics and persistence study, since all animals had the same dose, the only 
means of preventing bias was to blind the dates the animals were evaluated and include several 0  
Gy macaques.  The X-15 cohort that was provided by Wake Forest contained 10 macaques that 
received 4 Gy, 6 macaques that received 0 Gy, and 1000 blood smears across 10 slide boxes 
(Table 2). The boxes of blood smears were labeled with the window of time that corresponded to 
the blood smears they contained. A piece of tape was place over these labels and the boxes were 
randomly placed out of order.  In addition, when slides were pulled for evaluation the following 
day, a small piece of tape was placed over the date on the label on the slide itself.  As the slides 
were reconciled the following day, the tape was removed, and the handwritten data were 
transcribed to a spread sheet accordingly.  Complete models of the biokinetics and persistence 
study were not constructed until the conclusion of the microscope analysis, and the final 
macaque data were recorded on the digital spreadsheet.  
 Lastly, an image was taken of every PPHA found.  All images were reconciled and 
labeled with the associated macaque the day after evaluation at the same time the data and slides 
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were reconciled and added to the spreadsheet.  Images were inspected one by one on a large 
computer monitor to allow for close inspection of the cell’s morphology.  All cells that were 
erroneously determined as PPHAs were annotated in the laboratory notebook and the digital 
spreadsheet.  At the conclusion of every week, all images were reviewed once again, data on the 
spreadsheet were checked against the laboratory notebook, and microscope slides were returned 
to the appropriate box and placed in a complete pile. Time stamp labels on the slide boxes were 
not removed until all 10 slide boxes were placed in the complete pile so process of elimination 
and assumptions were not made on the time of slides being evaluated last.  
 
Data Analysis  
All values and figures were calculated and generated using Microsoft Excel spreadsheets. 
Furthermore, data collected for the dose response, biokinetics/prevalence, and baseline studies 
were compiled in mutually exclusive spreadsheets in Microsoft Excel.  Samples were not sorted 
by cohort (X-10/X-15), but by the studies in which they were involved, as indicated by Table 2, 
and they were entered into each spreadsheet that corresponded with the different studies.  For 
each sample, the number of PPHAs observed in a blood smear was compared to the total number 
of neutrophils counted to determine a percentage of cells with the PPHA morphology. Total 
neutrophil counts included the number of PPHAs, in lieu of PPHAs + 300 normal neutrophils , 
because the latter would produce a ratio instead of a percentage. Once every macaque for the 
dose response study was evaluated for PPHAs, the percentages were reconciled with the doses 
and a dose response was produced. Since the dose response had multiple animals clustered at 0, 
4, and 6.5 Gy, a box and whiskers plot was constructed to display the distribution of data within 
45 
 
the cohorts.  A Student’s t-test was performed between 0 and 4 Gy, 0 and 6.5 Gy, and 4 and 6.5 
Gy to evaluate the data for statistical significance.  
 Biokinetics/persistence involved 10 animals separated into 2 groups that were distinct 
from one another only by irradiation date (Appendix F). For this reason, a graph for each group 
(n=5 each) was constructed that displays the average of each time point since irradiation and the 
standard deviation of that day.  Since the 10 irradiated macaques were segregated into 2 groups 
and their irradiation dates were offset by 7 days, the compiled data were normalized between the 
2 groups to ‘weeks post irradiation’ as opposed to ‘days post irradiation’.  An average of all 10 
macaques was plotted as a function of weeks post irradiation and the standard deviation of that 
time point displayed.  An individual biokinetics/persistence curve that is plotted as PPHA 
percentage as a function of days post irradiation was constructed for all 10 macaques. Only one 
blood smear was available per macaque per time point so there is no standard deviation 
displayed.  Lastly, all 10 individual graphs were overlaid onto one single graph to display the 
PPHA percentage of all macaques as a function of days post irradiation. No standard deviation 
was reported , due to only one blood smear per day, per macaque being available for analysis. 
The prevalence of the PPHA morphology in 0 Gy rhesus macaques was compiled following 
completion of the biokinetics/persistence and the dose response studies for the calculation of a 
baseline prevalence. There was a complete overlap of the 0 Gy macaques and the other studies 
leading to the compilation of baseline animals to occur last. Once compiled an average and 
standard deviation were calculated.  









Pseudo Pelger-Huët Anomaly Baseline Prevalence in Rhesus Macaques (non-irradiated) 
 The baseline prevalence of the PPHA morphology in the Rhesus Macaques was 
determined to be 0.58 ±0.46% with a lower limit of 0% and an upper limit of 1%.  Baseline 
prevalence data took on a log-normal distribution. The distribution of baseline percentages of 
PPHAs can be seen in Figure 11, and the Macaque identification numbers with the individual 
percentage of neutrophils presenting with the PPHA morphology can be seen in Table 3.  
 
Figure 11. Distribution of the percentage of neutrophils presenting with PPHA morphology in 0 
Gy dose rhesus macaques. 
 
Table 3.  Baseline prevalence of pseudo Pelger-Huët anomalies in rhesus macaques. 
Macaque ID Radiation Dose (Gy) %PPHA 
1962 0.00 1.00 
1965 0.00 1.67 
1971 0.00 0.00 
1973 0.00 1.33 
1974 0.00 0.00 
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1975 0.00 0.67 
1976 0.00 1.00 
1977 0.00 0.33 
1979 0.00 0.67 
1982 0.00 0.00 
1960 0.00 0.33 
1967 0.00 0.00 
1968 0.00 0.72 
1969 0.00 0.33 
1970 0.00 0.67 
1972 0.00 0.33 
2061 0.00 0.67 
2065 0.00 0.67 




Pseudo Pelger-Huët Anomaly Dose Response in the Rhesus Macaques 
A linear dose response relationship was found between the percentage of neutrophils that 
presented the PPHA morphology and the acute radiation dose administered to the Macaque. The 
linear trendline displayed a positive correlation between PPHAs and radiation dose with an R2 of 
0.88. Blood smears for the dose response were taken from the animals at an average of 198 ± 8.2 
days following irradiation including the macaques used from the biokinetics/persistence study. 
Data points in the dose response graph are displayed as semi-translucent so that data points with 
multiple animals appear darker.  Each animal had only one blood smear available for analysis, so 
no average or standard deviation is reported. The dose response model and corresponding linear 
regression line can be seen in Figure 12. All data points on the dose response model were 
intentionally semi-translucent to show where multiple macaques are at a single data point. 
Macaque identification numbers, days post irradiation the smear was taken, whole body radiation 
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dose, and the corresponding percentage of neutrophils that presented with the PPHA morphology 
can be seen in Appendix F. 
 
Figure 12. Rhesus Macaques dose response displaying a linear relationship between the 
percentage of neutrophils presenting the PPHA morphology and acute radiation dose.  
 
 Dose response samples were clustered at 0, 4, and 6.5 Gy, and only 4 doses were outside 
those categories.  The number of animals and distribution of data can be seen in Table 4. 
Table 4. Averages of 0, 4, and 6.5 Gy rhesus macaques. 
 n Average PPHA (%) 
0 Gy 18 0.58 ± 0.46% 
4 Gy 17 2.57 ± 0.51% 




The upper limit of the 0 Gy macaques was larger than the lower limit of the 4 Gy 
macaques, and the averages of the 4 Gy and the 6 Gy macaques were less than two standard 
deviation from one another so Student t-tests were performed to test for statistically significant 
differences. The 0 Gy and 4 Gy cohorts were statistically different at the 95% confidence level, 
with a p-value of 1.34 ✕ 10-13.  The 4 Gy cohort and the 6.5 Gy cohort were statistically different 
at the 95% confidence level, with a p-value of 5.34 ✕ 10-4 (Figure 13).  
 
Figure 13. Rhesus macaque dose response with animals clustered by dose (0 Gy, 4 Gy, and 6.5 
Gy). Upper and lower limits of recorded values are denoted with the upper and lower whiskers 
on each plot. 
 
 
 The standard deviation of each cohort was expected to increase with increasing radiation 
dose due to the inherently random nature of damage due to ionizing radiation. In addition, 
cellular repair mechanisms respond at different rates in different individuals lending to an 
increased variance of outcomes. The standard deviation only increased minimally with 
increasing dose. Data associated with the box and whiskers plot above can be seen below in 
Table 5.  
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Table 5.  Rhesus Macaques dose response clustered by radiation dose. 
Animals Clustered by Dose 










1962 1.00 1962 2.00 1884 3.00 
1965 1.67 1965 3.34 1885 2.67 
1971 0.00 1971 3.01 1886 4.33 
1973 1.33 1973 3.00 1904 3.67 
1974 0.00 1974 2.01 1906 4.00 
1975 0.67 1975 3.34 1917 3.33 
1976 1.00 1976 2.34 1919 3.00 
1977 0.33 1977 3.00 2056 4.00 
1979 0.67 1979 2.69 Average 3.50 ± 0.59% 
1982 0.00 1982 2.00 
1960 0.33 2058 2.67   
1967 0.00 2059 2.67   
1968 0.72 2060 2.33   
1969 0.33 2062 2.67   
1970 0.67 2063 3.00   
1972 0.33 2064 2.00   
2061 0.67 2067 1.67   
2065 0.67 Average 2.57 ± 0.51%   
Average 0.58 ± 0.46%  
   
 
 
Pseudo Pelger-Huët Anomaly Biokinetics/Persistence Model in Rhesus Macaques Post-
irradiation 
 The 10 animals in the biokinetics/persistence study were evaluated for PPHAs prior to 
irradiation and post irradiation. Rhesus macaques acted as their own controls in this experiment, 
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and the average baseline percentage of PPHAs used for comparison with post irradiation PPHA 
percentages was calculated using only the 10 rhesus macaques irradiated with 4 Gy in the X-15 
cohort (Table 2). The 8 additional animals that received 0 Gy of irradiation were not factored 
into the baseline average for the biokinetics/persistence study. The average baseline percentage 
of PPHAs for control samples was 0.73 ± 0.58%. The earliest time point following irradiation 
that was available for analysis was 24-48 hours post-irradiation. The average prevalence of the 
PPHA morphology 24-48 hours post-irradiation was 1.94 ± 1.03%, which is an increase of 233% 
from pre-irradiation.  The next data point was 1.2 weeks post-irradiation, and the average 
prevalence of the PPHA morphology was 2.80 ± 0.60%, which is an increase of 350% from the 
baseline. Following one-week post-irradiation, the prevalence plateaued and was relatively 
constant. The increase in the prevalence of the PPHA morphology and up to 4 weeks post-
irradiation can be seen in Figure 14.  
 
Figure 14. Rhesus macaques average time to a steady increase in the prevalence of pseudo 




The last time point evaluated for each macaque had an average increased prevalence of 
PPHAs of 2.7 ± 0.28% which is a 338% increase from the pre-irradiation average PPHA 
prevalence of 0.73 ± 0.58%. When the average of the last time point is compared with the 
average of 1.2 weeks post irradiation (when the prevalence plateaued) a change of only -0.1% 
PPHA prevalence is observed over 3 years.  The change in prevalence from 1.2 weeks post-
irradiation to 3.1 years post irradiation is less than one standard deviation, indicating a negligible 
change in the prevalence and a persistence of the PPHA morphology to 3 years post irradiation. 
Furthermore, an average was taken of all PPHA evaluations across all animals in the study from 
the start of the prevalence plateau (1.2 weeks post-irradiation) through the end of the study (3.1 
years post-irradiation), and the average PPHA percentage was 2.7 ± 0.33% which is a 338% 
increase from the pre-irradiation average. 
All individual graphs and the averages segregated by group according to radiation date 
can be found in Appendix F. An overlay of the 10 independent biokinetics curves can be seen in 
Figure 15, an average of the 10 animals can be seen in Figure 16, and data associated with the 




Figure 15. Rhesus macaques biokinetics/persistence with 10 subject animals overlayed. 
 







Table 6. Rhesus macaque biokinetics/persistence with n-10 averaged at weeks post irradiation. 
Average Biokinetics/Persistence Group 1&2 (n=10) 
Weeks Post 
Irradiation 
Average PPHA (n=10) Std. Dev. (±) 
-1.00 0.73 0.58 
0.00 0.73 0.58 
0.22 1.94 1.03 
1.22 2.80 0.60 
2.72 2.64 0.47 
4.72 2.71 0.51 
7.71 2.63 0.48 
12.72 2.30 0.39 
18.29 2.57 0.27 
21.22 2.59 0.43 
27.86 2.73 0.47 
40.64 2.87 0.53 
52.07 2.53 0.45 
60.64 2.73 0.44 
77.14 2.80 0.42 
93.77 2.77 0.35 
117.93 2.93 0.62 
144.93 2.80 0.36 


















Rhesus Macaques Baseline Prevalence of PPHAs (Non-irradiated)  
The baseline prevalence of the PPHA morphology in rhesus macaques was found to be 
0.58 ± 0.46% (n=18).  Goans et al. reported a background percentage of PPHAs in humans to be 
4.4 ± 0.4% (n=16)(Goans, 2017).  A baseline prevalence of PPHAs is indicative that there are 
other causes for the PPHA morphology to be present in the peripheral blood besides an acute 
radiation dose that was investigated in this study. Furthermore, the average baseline is larger by 
several percent in humans, but the standard deviation is similar at a 0.06% difference, implying a 
common origin for the baseline PPHAs.  A probable cause of the baseline prevalence is age 
related and due to the accumulation of radiation dose from background radiation sources.  
Rhesus Macaques have a life expectancy of approximately 25 years and the average age of the 
zero Gy dose animals when blood smears were taken was 5.2 ± 1.3 years old. An average age of 
the humans in the control group was not reported by Goans et. al, but were given as equivalent to 
the exposed radiation workers in the retrospective study of the Y-12 criticality accident.  The 
individuals exposed in the accident were of working-class age and were much older than 5.2 
years (Goans, 2017).  The humans investigated for baseline prevalence were much older than the 
rhesus macaques studied, and this is a likely explanation for the much higher background 
prevalence of PPHAs in humans than in the macaques. The change in baseline prevalence of 
PPHAs as an organism ages warrants further investigation into how background radiation 





Rhesus Macaques Dose Response 
 The dose response study found a positive correlation between the percentage of 
neutrophils present in the peripheral blood with a PPHA morphology and acute radiation dose.  
A linear trendline of PPHA cells and radiation dose yielded an R-squared of 0.88.  The blood 
smears available to use were all archived samples, and since the biokinetics was unknown for the 
PPHA morphology following an acute radiation dose, the spectrum of radiation doses were 
limited to those available in a small window of time following the irradiation event. The largest 
spread of doses inside the narrowest available timeframe included 6 dose cohorts (0, 4, 6.4, 6.5, 
8, and 8.5 Gy) that were taken at 198 ± 8 days post irradiation. The 6.4, 8, and 8.5 Gy cohorts 
only contained 4 rhesus macaques total, so they are a part of the dose response model (Figure 12) 
but were removed from the box and whiskers plot (Figure 13).  A Students t-test confirmed a 
statistically significant difference between the 0 and 4 Gy cohorts, and the 4 and 6.5 Gy cohorts.  
 Detections limits and minimum dose for response could not be determined in this study.  
A statistical difference between the baseline macaques and the 4 Gy macaques was found, but 
there were no animals sampled between 0 and 4 Gy due to a lack of availability in the window of 
time chosen.  With the results of the biokinetics study showing that the maximum prevalence of 
the PPHAs was reached in 1.2 weeks and persistence was observed after that, future samples can 
be analyzed and added to the dose response outside of the 198 ± 8 day window to fill the gaps 
between the dose cohorts.  Additionally, LD 50/30 for rhesus macaques is reported to be 6.7 Gy, 
while LD 50/30 for humans is 3.5 Gy (MacVittie, Farese, Jackson, 2015). A lower LD 50/30 in 
humans demonstrates the need for determination of lower limits of detection so that decisions 




Rhesus Macaques Biokinetics/Persistence (Post-irradiation) 
Rapid increase of the PPHA morphology indicates that it can be used for quick estimation 
of dose, and persistence to 3 years demonstrates that it can be used for retrospective dose 
estimation as well.  However, only two blood smears were taken between irradiation and the 
peak PPHA percentage being reached, 1 day and 8 days post irradiation (Figure 14).  In the first 
day, nearly a 3-fold increase of PPHAs was reported going from a baseline of 0.7% to 1.9%.  In 
the next week, the PPHA percentage increased further to a 4-fold increase of 2.8% (Table 6).  To 
characterize the rise in prevalence of the PPHA morphology more accurately, blood smears need 
to be taken at regular intervals until the reported values plateau.  The estimated blood sampling 
interval for PPHA in future studies should be approximately 5 hours, based on Goans et. al 
reporting a rise in PPHA quantities in as little as 5 hours.  Methods of extracting blood from the 
animal will need to be determined with the well-being of the animal’s health in mind.  The 
frequent handling and extraction of biological samples can cause a significant amount of stress 
and may lead to premature death.  
A trendline was drawn between the irradiation date and one day post irradiation (y = 
5.6279x + 0.73) and when the maximum value of 2.8% PPHAs was entered into the trendline 
equation, the interpolated time to reach maximum PPHA concentration is estimated to be 62 
hours post irradiation if the rate of increase was constant (Figure 14). A 5-hour interval of 
sampling would result in 13 time points until the plateau is reached. Unfortunately, additional 
sampling was not possible as this was a retrospective study, and future research would require 
different animals. However, the 10 macaques in the biokinetics study are still alive with samples 
being taken periodically, so the persistence models can be extended from 3.1 years to 4 years 
post irradiation as of December 2020 (Figure 15 and 16).   
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Possible Reasons for PPHA Persistence When Compared to Other Biodosimetry Methods 
 The dicentric chromosome assay (DCA) and translocations are currently very well 
calibrated in biodosimetry, while the PPHA assay is still a novel approach. There were no DCAs 
conducted on the animals in this study, but the persistence of the PPHA can be compared with 
the biokinetics/persistence of dicentric chromosomes and translocations. Most of the dicentric 
chromosome data that have been produced are from acute radiation exposures like the ones 
received by the rhesus macaques in this study.  The DCA is persistent in human peripheral blood 
from between three months to six months post exposure.  Past the 6-month timepoint 
translocations were far more effective at estimating dose through Fluorescent In-situ 
Hybridization (FISH) techniques and fluorescent microscopy (Romm, et al., 2009). Dicentric 
chromosomes are an unstable aberration because they do not persist beyond cell division, 
whereas translocations, that are easily detected, can pass through mitosis and carry on the 
mutation to the daughter cells (Romm, et al., 2009).  
 Studies conducted on 16 individuals that survived the Goiania, Brazil radiological 
incident had DCAs performed to determine the half-life of dicentric chromosomes in peripheral 
lymphocytes.  Humans exposed to over one Gy exhibited a dicentric chromosomes half-life of 
110 days, with an elongation of up to 470 days as time progressed over a 6-year study (Ramolho, 
Curado, & Natarajan, 1995).  The elongation of the half-life of lymphocytes expressing 
dicentrics is possibly due to a variability in lifespan of T-lymphocytes.  It is still widely debated 
what the lifespan of the various subsets of T-lymphocytes are and the turnover rate is highly 
variable and unknown, potentially ranging between several days to several years (Ramolho, 
Curado, & Natarajan, 1995). This indicates that in the beginning, short lived T-lymphocytes 
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would die off quickly exhibiting a fast removal rate, but eventually leaving the long-lived T-
lymphocytes to elongate the removal rate over time.  
PPHAs present themselves in granulocytes versus T-lymphocytes, and granulocytes have 
an average lifespan in the blood of around 8 hours (Ramolho, Curado, & Natarajan, 1995). 
PPHAs have persisted in rhesus macaques for 3 years despite the extremely short lifespan of 
neutrophils because the cells suspected of being affected by radiation are progenitor cells and 
hematopoietic stems cells in the bone marrow.  The exact mechanism that causes the formation 
of PPHAs is unknown, but there are two possibilities for PPHA proliferations. First, a mutation 
in chromosome one impacts translation of the lamin-b receptor and degrades the integrity of the 
nuclear membrane.  Second, a physical interaction of radiation with chromatin causes a bridge 
being formed and the cell is unable to complete cytokinesis or unable to fully segment.  
In the case of chromosome one mutation, the hematopoietic stem cells would be affected. 
Hematopoietic stem cells can be long-lived, allowing for mutations to persist for potentially 
decades.  The undifferentiated hematopoietic stem cells are far more radiosensitive than post-
mitotic neutrophils so hematopoietic stem cells are more likely to be impacted by a mutation. A 
mutation could account for the persistency of the PPHA morphology while a dicentric 
chromosome in the hematopoietic stem cells would result in cell death. However, non-human 
primates have presented the PPHA morphology in as little as 5 hours post irradiation, which is 
very quick for a hematopoietic stem cell mutation to manifest (Goans, 2017). An argument for a 
physical interaction of the radiation with immature neutrophils could cause chromatin bridges to 
form and potentially lead to hypo-segmentation of the granulocyte nuclei.  Given that there are 
on average 100 billion neutrophils produced by the bone marrow daily, there is a large potential 
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for interaction with developing cells that are post mitotic and maturing with the help of 
chemokines and other cellular messengers.  
 
Ergonomic Hazards of this Study 
 This study was conducted using a light microscope on a bench top.  Each blood smear 
took between 20 and 45 minutes to evaluate for the PPHA assay, and total time spent performing 
PPHA assays was estimated to be about 500 hours.  The amount of time using the microscope, 
the chair available for use, and the height of the microscope when compared to the height of the 
evaluator all presented with ergonomic hazards.  Severe neck and back pain was common, and 
long periods of evaluation were not possible which impacted the pace at which blood smears 
were evaluated negatively.  All ergonomic hazards were mitigated at the 100-hour mark of 
analysis and the pace of evaluation was able to speed up drastically due to reduced neck and 
back pain.  An ergonomic chair with lumbar support and adjustable height was purchased.  
Lumbar support mitigated lower back pain, while the adjustable height of the chair and placing 
the microscope on several textbooks to elevate it removed the upper back and neck pain.  
Additionally, a pad was added to the bench top to mitigate pressure on elbows and subsequent 
numbness in hands from pressure directly to the ulnar nerve.  
 
Limitations of Results 
 The presence of the PPHA morphology in peripheral blood smears may be useful as an 
inexpensive and effective biomarker of acute radiation exposure. However, the relationship 
between the percentages of neutrophils that display the PPHA morphology and acute radiation 
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dose needs strengthening to ensure confidence in the macaque models and translation to humans 
in a mass casualty incident. The dose response is limited by the small number of cohorts that 
were available for evaluation. The biokinetics study was limited because blood smears were 
taken at only two time points in the first week following irradiation. Lastly, the persistence 
model was only evaluated to 3.1 years and a point where the peripheral prevalence of PPHAs 
begins to drop was not found.  
In addition, the lack of other biodosimetry methods in the current sample population is 
concerning because assays such as the dicentric chromosome assay are the currently accepted 
standard of bio-dosimetry and would need to be conducted in parallel to validate the PPHA assay 
as a biomarker of acute radiation dose. Secondly, the differentiation of the PPHA from normal 
neutrophils is conducted purely from visual inspection, which can be very subjective. While 
images were taken to verify the decisions, a molecular characterization and the origin of the 
PPHA morphology could make determining what is a PPHA and what is a normal neutrophil 
















Expanding Dose Response, Biokinetics, & Persistence 
For future work, additional archived blood smears from the Wake Forest School of 
Medicine, Department of Comparative medicine can be obtained and evaluated for PPHAs to 
expand on models constructed in this study.  The X-10 cohort has over 8100 blood smears 
archived, and only 37 were evaluated for the construction of the dose response model in the 
window of 198 ± 8 days post irradiation. The results of the persistence study indicate that 
evaluation in such a small window of time is unnecessary, so the dose response can be expanded 
using additional blood smears from additional monkeys outside of the originally time point of 
198 ± 8 days post irradiation.   
Future studies should evaluate the X-10 cohort for blood smears taken in the first week 
post exposure to further define the time for an increased prevalence of PPHAs to occur post-
irradiation.  Initial searches of the X-10 cohort indicate that some primates had several smears 
taken in the first 72 hours post irradiation.  Evaluation of more blood smears will better define 
PPHA response during the first week following irradiation, helping to determine the lower limits 
of detection, and derive correction factors for the ‘time since irradiation’ for PPHA assays 
conducted in the first 48-72 hours after an acute radiation dose.  
As the 10 macaques from the X-15 cohort age, blood smears will continue to be taken at 
6-month intervals. Evaluation of the X-15 cohort for PPHAs over time will build upon the 
biokinetics/persistence models constructed in this study. In addition to the X-15 
biokinetics/persistence macaques, the macaques from the X-10 cohort had periodic blood smears 
taken as a part of periodic health checkups.  Blood smears from the X-10 cohort can be selected 
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and persistence models of the PPHA morphology can be built for different doses besides 4 Gy 
and for periods as long as 15 years.  
 
Validation of the Pseudo Pelger-Huët Anomaly Against Current Methods 
 Additional research is required to validate the PPHA morphology as a biomarker of 
radiation exposure.  Trends have been illustrated in bats, humans, boar, and now rhesus 
macaques but PPHAs have not been compared to other forms of biodosimetry.  A parallel study 
needs to be conducted where multiple methods of biodosimetry are performed and compared to 
the PPHA assay to validate the method. For validation, dicentric chromosome assays (DCAs) 
from peripheral lymphocytes would be analyzed in tandem with the whole blood taken from 
rhesus macaques.  Further characterization of the initial increase in PPHA prevalence in the first 
several days post irradiation would maximize the efficiency of this study.  DCAs should be 
performed on peripheral blood in tandem with PPHA assays when the PPHA persistence plateau 
has been reached in the biokinetics model.  In addition to DCAs, that have a half -life in the 
peripheral blood of 110 days, translocations should be determined, as they are far more stable 
aberrations passed to daughter cells during cell division (Ramolho, Curado, & Natarajan, 1995). 
DCAs can be used to validate PPHAs for the first several months post irradiation and 
translocations can be used to validate long term persistence. 
 
Molecular Characterization and Pinpoint Origin of the Pseudo Pelger-Huët Anomaly 
 Rhesus macaques are frequently used as translational models for biomarkers since their 
blood physiology is nearly identical to humans and they are abundantly available. Radiation 
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doses were well characterized in this study, however, in many exposure scenarios the doses are 
merely estimated, so a correlation between PPHA assays and DCAs is necessary. If the PPHA 
assay is validated against the dicentric chromosome analysis (DCA), further studies should be 
done on hematopoietic stem cells (HSC) from rhesus macaques. The movement of the PPHA 
assay forward with HSCs would require funding that would require the justification provided by 
this validation with DCA. The use of HSCs would help to discover where in the process of 
granulopoiesis the damaging event takes place that causes the PPHA morphology to occur.  This 
insight would narrow the scope of work to help determine what that damaging event is, whether 
it be a double strand break, a mutation, or any other mechanism that would cause a change in the 
nuclear morphology.    
A consensus has been reached on the necessity of a bi-lobed structure to consider the 
cells a PPHA, however there is still debate on what comprises the thin nuclear bridge that 
connects the two lobes.  As previously discussed, PHAs are caused by a mutation on 
chromosome 1 that encodes for the lamin-B receptor. This mutation disrupts the integrity of the 
structural components in the nucleus and results in the abnormal morphology (Collela & 
Hollensead, 2012).  PPHA prevalence has been observed to increase in 5 hours post irradiation in 
previous experiments, and in the first 24 hours here (Goans, Iddins, Ossetrova, Ney, & Dainiak, 
2017). The rapid manifestation of the PPHA morphology is contradictory to the idea that a 
mutation is responsible, however since neutrophils are rapidly produced in the bone marrow and 
sent to the peripheral blood a mutation could be the cause. Further investigation of the 
composition of the PPHA bridge must be conducted. One possible approach is to use electron 
microscopy to image the bridge, and another could be to use fluorescent probes.  If the bridge is 
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comprised of a dicentric chromosome being pulled between two segmentations a centromere 
probe could be utilized. 
Furthermore, if the PPHA morphology is caused by ionizing radiation generating a 
double strand break in the genome of the cell, hematopoietic stem cells could be used as a 
diagnostic tool.  Cultured HSCs would be induced into differentiation and irradiated at different 
stages.  However, the cells will not be harvested at each stage but instead allowed to mature as 
neutrophils.  When harvested, the white blood cells (WBC) can be isolated from red blood cells 
using a hypotonic solution or serum separation tubes.  This is intended to increase the 
concentration of WBCs on the slide for faster and consistent analysis. Using the cytospin 
technique the WBCs will adhere to a glass slide and then subsequently be fixed with methanol.  
Fluorescent In Situ Hybridization (FISH) would allow for an analysis of the nuclear region of 
cells with the added insight of segregating the chromatin.  The fluorescence can be analyzed 
using a computer program called Metafer and a metasystems microscope that reads the 
differential fluorescent probes on the chromatin and produces a computer-generated image that 
color codes the chromatin.  The bridge connecting the bilobed structure would then be 
characterized to determine which chromatin are contained in the bridge, if a dicentric 
chromosome is present, and if it is a random event or not.  A metasystems microscope and 
Metafer programing is available to this project through collaborations with Oak Ridge Associate 
Universities and the Biodosimetry lab with the International Atomic Energy Agency. 
Lastly, if a mutation is responsible for the PPHA morphology, experiments can be 
conducted to look for consistent mutations in the genome of PPHAs, and  consistent changes in 
proteins produced by them during granulopoiesis. PHAs are caused by a defect in the lamin -B 
receptor gene, so Western blotting and DNA-polymerized chain reaction may be utilized to 
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image the lamin-b receptor and the lamin-b receptor gene, respectively.  First, the experiment 
would need to be conducted in-vitro with excised hematopoietic stem cells grown in medium so 
that the differentiation can be controlled.  Colony stimulating factors and interleukins would be 
selectively given to induce differentiation of the hematopoietic stem cells.  At each stage of 
differentiation, an irradiated cohort would be harvested and analyzed to be compared to an 
unirradiated cohort. Some cells from each cohort would be pulverized using a Sonicator and 
evaluated for the lamin-b receptor using Western blot.  In addition, the genome can be sequenced 
using DNA-PCR to investigate mutations directly.  This experiment would also provide insight 
into which stage of differentiation is most likely to be causing the PPHA morphology to occur. 
 
Automation of Analysis for Efficiency in Mass Casualty Incidents 
For the PPHA assay to be used as a fast and effective biomarker in a mass casualty 
incident the need for an automated high throughput system is clear.  Existing technology can be 
modified and eventually optimized to perform this task.  Metasystems microscopes and the 
corresponding Metafer software is already being optimized for high through put dicentric 
chromosome assays with Oak Ridge Associated Universities in Oak Ridge, Tennessee, and soon 
to be installed at the biodosimetry laboratory for the International Atomic Energy Agency in 
Seibersdorf, Austria. However, there are many challenges to face when using the metasystems 
microscope for a cellular assay versus a genomic assay.   
 First, DCAs are prepared in such a way that there is inherently a monolayer thickness of 
the sample that is being analyzed.  When the metasystems microscope analyzes the DCA slide, it 
is manually focused in several random locations on the slide and then the microscope scans it 
automatically taking pictures of chromosome spreads that are thought to have dicentric 
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chromosomes by the Metafer software. As the microscope completes a slide, it can automatically 
change to a new slide and analyze the slide thoroughly.  Blood smears are inherently not a 
monolayer of thickness. To achieve the monolayer of thickness of cells, red blood cells can be 
lysed and the cytospin technique that was previously discussed could be used to evenly distribute 
the remaining white blood cells on a glass slide.   
 Secondly, the size and shape of the PPHA morphology needs to be clearly defined for 
visual inspection. If automation is functioning correctly, any cell with two lobes and a thin 
bridge between them will need to be photographed by the microscope, and a human worker will 
need to verify the cells are PPHAs. Thickness of the thin bridge connecting the two lobes of 
PPHAs needs to be exactly characterized for the automation to correctly identify PPHA cells.  As 
the metasystems microscope is scanning, it can be taught to take pictures of anything that is 
below a certain thickness. However, the thickness of the bridge can match the thickness of 
bridges connecting the lobes of a normal neutrophil, so in addition to bridges the number of 
lobes would also need to be identified.  The number of lobes would be a challenge to automate 
because the PPHA lobes are not all perfectly round lobes as portrayed in literature.  There is a 
risk of bias that has been generated by the skewing of the PPHA imagery in the literature due to 
utilizing the most photogenic PPHA cells, rather than illustrating the variety of shapes that 
manifest.    
 Lastly, consistency is paramount when it comes to developing the PPHA assay.  A 
standardized approach to extracting the blood sample, performing the blood smear, drying, 






In conclusion, our hypothesis was proven correct that the pseudo Pelger-Huët anomaly 
(PPHA) , through the following four specific aims addressed in this study, has definitively been 
proven to be a biomarker for acute radiation dose in rhesus macaques: (1) Established a baseline 
prevalence of PPHAs, in the peripheral blood of rhesus macaques, (2) established a dose 
response curve across a variety of acute doses, (3) established a biokinetics and persistence 
model, and (4) determined future studies required to validate and optimize the PPHA assay for 
use as a method of biodosimetric analysis.  
The PPHA assay is performed by taking a peripheral blood smear that has been stained 
with a nuclear staining dye such as Giemsa-Wright stain and evaluated using a light microscope 
to determine the percentage of neutrophils presenting the PPHA morphology. Previous resea rch 
projects have produced preliminary data for acute radiation exposure scenarios, but many 
questions were left unanswered (Goans, 2015).  Biological samples from acutely exposed rhesus 
macaques were obtained to answer many of these questions, and PPHA assays were performed 
on them to expand on the previously discovered evidence for the efficacy of the PPHA assay as a 
biomarker of radiation. 
Part one of this study consisted of establishing a baseline prevalence of PPHAs in the 
peripheral blood of rhesus macaques.  The baseline prevalence was found to be 0.58 ± 0.46% 
(n=18).  Background radiation is an important consideration for both the baseline and the 
persistence of the PPHA assay, as PPHA morphology is thought to be induced by chronic low 
dose radiation exposures as well.  Age may be a large factor in the efficacy of the PPHA assay 
and correction factors could be required.  Previous research found that humans have a 
background prevalence of PPHAs of 4.4 ± 0.4%. The baseline prevalence of PPHAs in rhesus 
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macaques was much lower than that of human, but the standard deviation of the data was only 
0.06% different.  This difference in baseline PPHA prevalence is likely due to the rhesus 
macaques only being on average 5.2 years old when blood smears were taken,  while control 
humans were adults over 18 years old. An older age leads to a larger accumulation of dose from 
background radiation, therefore changing the baseline prevalence dramatically with a change in 
age of the victim. The baseline change in PPHAs over time necessitates the investigation of 
correction factors for age in future research. 
Part two of this study consisted of establishing a dose response curve across a variety of 
acute doses ranging from zero Gy dose to 8.5 Gy (LD90/30) for the rhesus macaques (MacVittie, 
Farese, & Jackson, 2015). A dose response curve was constructed (n =47) and a strong 
correlation was found between the percentage of neutrophils in the peripheral blood that 
presented with the PPHA morphology and acute radiation dose, with an R-squared of 0.88.  
Rhesus macaque blood was analyzed for increasing PPHA cells clustered at 0 Gy (n=18), 4 Gy 
(n=18), and 6.5 Gy (n=8), so a Students t-test was performed between 0 and 4 Gy, and 4 and 6.5 
Gy.  A statistically significant difference was found in both Student t-tests.    
Part three of this study established a biokinetics and persistence model that illustrates how 
quickly the PPHA morphology manifests and how long they are persistent following acute 
radiation exposure. Ten rhesus macaques were exposed to a single 4 Gy dose at a rate of 80 cGy 
min-1 and blood smears taken at 19 different time points following exposure. One blood smear 
was taken prior to irradiation so each animal acted as its own control. The prevalence of the 
PPHA morphology increased sharply and reached a maximum level at 8 days post irradiation.  
The maximum PPHA level plateaued and was persistent at this level until the end of available 
blood smears at 3.1 years post irradiation.  
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This study was intended to expand upon the methodologies available to biodosimetrists for 
early and retrospective radiation dose estimations for individuals that have been exposed to acute 
doses of ionizing radiation. While the models built for this project are more robust than previous 
studies, shortcomings are present.  The dose response model has dose cohorts versus a spectrum, 
the first week post-irradiation needs to be characterized further, and the persistence was not 
observed past 3 years so a time related reduction of the PPHA morphology in peripheral blood 
was not found. Future projects will include analysis of more zero dose rhesus macaques to 
increase confidence in baseline, an expansion of the dose response model by adding additional 
animals to increase a variety of doses, extending the biokinetics model beyond the available 3.1 
years of blood smears, and increasing frequency of blood smears taken immediately following 
irradiation to better characterize the initial peak of PPHA prevalence. Additional anticipated 
areas of research that can be done to continue this project are to molecularly characterize the 
PPHA morphology, seek to validate the PPHA assay with dicentric chromosome analysis, and 
investigating the efficacy of PPHA assay automation using metasystem microscopes that are 
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APPENDIX C: OCCUPATIONAL SAFETY AND HEALTH ZOONOTIC CONCERNS 









































APPENDIX F: RHESUS MACAQUE DATA TABLES AND MODELS FOR INDIVIDUALS 
IN THE BIOKINETICS/PERSISTENCE STUDY 
 
Table 7.  Rhesus macaques dose response data. 
Rhesus Macaque Dose Response Data 
Animal ID 
Days Post Irradiation 









1962 N/A 0 3 1.00 
1965 N/A 0 5 1.67 
1971 N/A 0 0 0.00 
1973 N/A 0 4 1.33 
1974 N/A 0 0 0.00 
1975 N/A 0 2 0.67 
1976 N/A 0 3 1.00 
1977 N/A 0 1 0.33 
1979 N/A 0 2 0.67 
1982 N/A 0 0 0.00 
1960 N/A 0 1 0.33 
1967 N/A 0 0 0.00 
1968 N/A 0 2 0.72 
1969 N/A 0 1 0.33 
1970 N/A 0 2 0.67 
1972 N/A 0 1 0.33 
2061 195 0 2 0.67 
2065 195 0 2 0.67 
1962 198 4 6 2.00 
1965 193 4 10 3.34 
1971 198 4 9 3.01 
1973 193 4 9 3.00 
1974 199 4 6 2.01 
1975 192 4 10 3.34 
1976 193 4 7 2.34 
1977 192 4 9 3.00 
1979 198 4 8 2.69 
1982 199 4 6 2.00 
2058 195 4 8 2.67 
2059 195 4 8 2.67 
2060 195 4 7 2.33 
2062 195 4 8 2.67 
90 
 
2063 195 4 9 3.00 
2064 195 4 6 2.00 
2067 195 4 5 1.67 
1892 223 6.4 14 4.67 
1884 203 6.5 9 3.00 
1885 196 6.5 8 2.67 
1886 183 6.5 13 4.33 
1904 210 6.5 11 3.67 
1906 204 6.5 12 4.00 
1917 203 6.5 10 3.33 
1919 184 6.5 9 3.00 
2056 209 6.5 12 4.00 
1910 201 8 14 4.67 
2053 217 8 16 5.33 
1905 204 8.5 15 5.00 
 
 Average Days Post 





























Group 1 Biokinetics, Rhesus Macaques, Irradiation date 10/23/2016 (4Gy dose 
 
 
Figure 18. Rhesus macaque biokinetics/persistence, average PPHA concentration of group 1 
(rhesus macaque ID 1962, 1971, 1974, 1979, & 1982). 
 
Table 8. Rhesus macaque biokinetics/persistence, average PPHA concentration of group 1 
(rhesus macaque ID 1962, 1971, 1974, 1979, & 1982).  
Average Biokinetics/Persistence Group 1 (n=5) 
Days Since Irradiation Average PPHA % Std.Dev (±) 
-6 0.33 0.47 
0 0.33 0.47 
1 0.92 0.69 
8 2.75 0.57 
15 2.49 0.15 
29 2.58 0.32 
43 2.40 0.64 
57 2.60 0.43 
92 2.20 0.38 
128 2.47 0.30 
148 2.53 0.30 
198 2.47 0.38 
288 2.73 0.64 
368 2.27 0.28 
428 2.60 0.37 
543 2.73 0.49 
659 2.67 0.47 
829 2.73 0.72 
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1018 2.67 0.41 
1125 2.83 0.19 
 
 
Figure 19. Biokinetics/persistence diagram for macaque 1962. 
 
Table 9. Biokinetics/persistence for macaque 1962. 
1962 




















Figure 20. Biokinetics/persistence diagram for macaque 1971. 
 
 
Table 10. Biokinetics/persistence for macaque 1971. 
1971 






















Figure 21. Biokinetics/persistence diagram for macaque 1974. 
 
Table 11. Biokinetics/persistence for macaque 1974. 
1974 






















Figure 22. Biokinetics/persistence diagram for macaque 1979. 
 
Table 12. Biokinetics/persistence for macaque 1979. 
1979 























Figure 23. Biokinetics/persistence diagram for macaque 1982. 
 
Table 13. Biokinetics/persistence for macaque 1982. 
1982 





















Group 2 Rhesus Macaques, Irradiation date 10/23/2016 (4Gy dose): 
 
 
Figure 24. Rhesus macaque biokinetics/persistence, average PPHA concentration of group 2 
(rhesus macaque ID 1965, 1971, 1975, 1976, & 1977).  
 
Table 14. Rhesus macaque biokinetics/persistence, average PPHA concentration of group 2 
(rhesus macaque ID 1965, 1971, 1975, 1976, & 1977). 
Average Biokinetics/Persistence Group 2 (n=5) 
Days Post Irradiation Average PPHA % Std. Dev (±) 
-5 1.13 0.38 
0 1.13 0.38 
2 2.63 0.80 
9 2.83 0.44 
23 2.75 0.69 
37 2.83 0.43 
51 2.67 0.61 
86 2.42 0.42 
128 2.67 0.24 
149 2.67 0.61 
192 3.00 0.41 
281 3.00 0.41 
361 2.80 0.45 
421 2.87 0.51 
537 2.87 0.38 
652 2.87 0.18 
822 3.13 0.51 
1011 2.93 0.28 




Figure 25. Biokinetics/persistence diagram for macaque 1965. 
 























Figure 26. Biokinetics/persistence diagram for macaque 1973. 
 



























Figure 27. Biokinetics/persistence diagram for macaque 1975. 
 



























  Figure 28. Biokinetics/persistence diagram for macaque 1976. 
 



























Figure 29. Biokinetics/persistence diagram for macaque 1977. 
 


























APPENDIX G: MAKING A BLOOD SMEAR 
 
1. Place a drop of blood that is roughly 10µL in volume near one end of a blood slide.  
2.  quickly take a second slide and while holding it at an angle above the slide containing 
the drop of blood contact the slide as seen in Figure 30.  
a. It is important to do this quickly because the blood will coagulate rapidly in air.  
  
   
Figure 30. Placement of second slide in the process of creating a blood smear.  
3.  While ensuring that contact is maintained between the two slides draw the top slide 
back towards the blood drop slowly. Capillary action will cause the blood to spread out 
along the glass surface depicting in Figure 31.  
             
Figure 31. Drawing back the top slide as to contact the blood drop. 
4. In a quick motion push the top slide forward. The blood with smear behind the slide in a 
uniform fashion as depicted in Figure 32.  Ideally the resulting smear will have a 




Figure 32. Placement of second slide in the process of creating a blood smear. 
5. Allow the blood to dry and then using an eye dropper coat the smear in 100% methanol 
to fix the cells in place.  

































APPENDIX H: GIEMSA STAINING BLOOD SMEARS 
 
1. Ensure that blood smears are fixed in methanol and properly dried and labeled.  
a. If an ink pen is used for labeling methanol will cause the label to run. Write label 
with pencil and write over with a permanent marker once slides are fully 
prepared.   
2. Prepare a 5% Giemsa stain in GURR 
a. GURR buffer solution preparation:  
i. Add 1 tablet to 100mL dH2O → dissolve  
ii. GURR buffer tablets can be seen in Figure 33.  
 
Figure 33. GURR buffer tablets used in preparation of Giemsa stain 
b. Add 2.5mL Giemsa solution to 47.5mL GURRin a Coplin jar 
3. Submerge slides in Giemsa solution for 45 minutes in a Coplin jar.  




Figure 34. Giemsa stained blood smears. 
5. Submerge slides in xylene to ensure all oils are removed.  
6. Mount coverslip with Permount mounting medium.  
a. Apply pressure to the coverslip to remove any air bubbles. 
b. Clean any excess mounting medium that is forced out from under the coverslip. 
7. Store in cool dry place. Avoid keeping them for extended periods of time in hot vehicles 
if transporting them. 
